<SEC-DOCUMENT>0001558370-24-009097.txt : 20240612
<SEC-HEADER>0001558370-24-009097.hdr.sgml : 20240612
<ACCEPTANCE-DATETIME>20240612164521
ACCESSION NUMBER:		0001558370-24-009097
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20240611
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240612
DATE AS OF CHANGE:		20240612

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MAXCYTE, INC.
		CENTRAL INDEX KEY:			0001287098
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				522210438
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40674
		FILM NUMBER:		241038970

	BUSINESS ADDRESS:	
		STREET 1:		9713 KEY WEST AVENUE,
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		301-517-5556

	MAIL ADDRESS:	
		STREET 1:		9713 KEY WEST AVENUE,
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MAXCYTE INC
		DATE OF NAME CHANGE:	20040415
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mxct-20240611x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.6.2.5 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 6/12/2024 3:21:52 AM -->
<!-- iXBRL Library version: 1.0.8826.24652 -->
<!-- iXBRL Service Job ID: 94b0fde9-bbbe-401a-8e5f-e0c51f2e4fc8 -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:mxct="http://www.maxcyte.com/20240611" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:EntityCentralIndexKey" id="Tc_iait9iqWe0KzzpCYJsxaDQ_2_1">0001287098</ix:nonNumeric><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:AmendmentFlag" id="Tc_W0s3bSF1-ECZEbKOKnVvcg_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="mxct-20240611.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001287098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-11</xbrli:startDate><xbrli:endDate>2024-06-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-bottom:1pt;padding-top:1pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><a id="_1a734a45_c592_4798_ad40_00e8a60392d3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Washington, DC 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;text-align:center;margin:0pt 0pt 4pt 0pt;"><b style="font-weight:bold;">FORM </b><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:DocumentType" id="Narr_fvUiFGb4Y0Ce_xWlj6btjg"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">The Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Date of Report (Date of earliest event reported): </b><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_DsobfeVuO0uPz7M-hQxZ6Q"><b style="font-weight:bold;">June 11, 2024</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:EntityRegistrantName" id="Narr_FVIIqARxg0Ss8Fh84eeMHQ"><b style="font-weight:bold;">MaxCyte, Inc.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><a id="_e037aa59_1551_45dd_a44e_a9e3f33790fe"></a><a id="Tc__3B_obtl-kWuqZv5UXh-5w_2_0"></a><a id="Tc_-kdJPlUtpU2Ax_nbDPoIPA_2_2"></a><a id="Tc_2kYBgvc_jESsAmcJ1BJFTA_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:31.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:31.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:31.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:31.95%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_kVnQpRtAc0ePgKgxHRurXQ_1_0"><b style="font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:31.95%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:EntityFileNumber" id="Tc_OCtxRVeRQkGdbxkqX2c8bg_1_2"><b style="font-weight:bold;">001-40674</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:31.95%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:EntityTaxIdentificationNumber" id="Tc_SOLMHBfThkuE2YUNqBnhmA_1_4"><b style="font-weight:bold;">52-2210438</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:31.95%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(State or other jurisdiction of <br/>incorporation)</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.95%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Commission File Number)</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.95%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(IRS Employer<br/>Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:EntityAddressAddressLine1" id="Narr_7jEmmpSrqEa6vaqnpyjk3w"><b style="font-weight:bold;">9713 Key West Avenue</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:EntityAddressAddressLine2" id="Narr_jSwY3g319EiFeFO2PWuIRA"><b style="font-weight:bold;">Suite 400 </b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:EntityAddressCityOrTown" id="Narr_O7KtVj3NQkWqMD9sA8Et2A"><b style="font-weight:bold;">Rockville</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="Narr_p-THdNZc1UqmSNVfu4JHtQ"><b style="font-weight:bold;">Maryland</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:EntityAddressPostalZipCode" id="Narr_tbrWHT1eVkOeWLcow9WUvw"><b style="font-weight:bold;">20850</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 4pt 0pt;"><span style="white-space:pre-wrap;"> (Address of principal executive offices, including zip code)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:CityAreaCode" id="Narr_3SngV7YVcEiAETBCSYJJwA"><b style="font-weight:bold;">301</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:LocalPhoneNumber" id="Narr_T8XdR7A6TUaSJj9GBQQ-_w"><b style="font-weight:bold;">944-1700</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 4pt 0pt;">(Registrant&#8217;s telephone number, including area code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">N/A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Former name or former address, if changed since last report)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.25pt;text-indent:-14.25pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_KXy9C2EscU-QCsiduycjPA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.25pt;text-indent:-14.25pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_N6m9dfRbdU-F_yNblfKkkg"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.25pt;text-indent:-14.25pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_MXyRRIkXa0WWuwHNghmf9A"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.25pt;text-indent:-14.25pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_XKCLBZZAMU6VwWXpBp9PrA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.25pt;text-indent:-14.25pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Securities registered pursuant to Section&#160;12(b) of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_5382f6aa_4659_4a7f_b1ff_b31de2a8edf2"></a><a id="Tc_eqq-If_710WLXPbFaRMyAQ_1_0"></a><a id="Tc_lkTVTBVDkEOLqPr7oJjb_A_1_2"></a><a id="Tc_INgM5qPBskygDlV67FZ7sA_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:32%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:bottom;width:1.99%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:32%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Symbol(s)</b></p></td><td style="vertical-align:bottom;width:1.99%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:32%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name of each exchange</b> <br/><b style="font-weight:bold;">on which registered</b></p></td></tr><tr><td style="vertical-align:bottom;width:32%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:Security12bTitle" id="Tc_k5kDnfOCtUKedGE9g5yx7w_2_0"><b style="font-weight:bold;">Common Stock, $0.01 par value</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:32%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" name="dei:TradingSymbol" id="Tc_8TuH02i7NUeaYaDbGrKgdw_2_2"><b style="font-weight:bold;">MXCT</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:32%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_OcyzT0M0d0-ZFCEVTJV8wg_2_4"><b style="font-weight:bold;">The Nasdaq Stock Market LLC</b></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934&#160;(&#167;240.12b-2&#160;of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Emerging growth company &#160;&#160;&#160;<ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_Yo0oUdZ6K0yjLYQR3yBPSA"><span style="font-family:'Segoe UI Symbol';">&#9746;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial account standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="Narr_D_l7W8nag0KncLV-er1OKA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt 0pt 10pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_cd79ea0e_edb6_441c_931f_37df31429341"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:46.8pt;text-indent:-46.8pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">At the 2024 annual meeting of stockholders of MaxCyte, Inc. (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;) held on June 11, 2024 (the &#8220;<span style="font-style:italic;font-weight:bold;">Annual Meeting</span>&#8221;), the Company&#8217;s stockholders approved an Amendment (the &#8220;<span style="font-style:italic;font-weight:bold;">Plan Amendment</span>&#8221;) to the MaxCyte, Inc. 2022 Equity Incentive Plan, as amended (the &#8220;<span style="font-style:italic;font-weight:bold;">2022 Plan</span>&#8221;). The Plan Amendment increases by 2,300,000 the maximum number of shares of common stock authorized to be issued under the 2022 Plan. Further information regarding the Plan Amendment was provided in the Company&#8217;s definitive proxy statement filed with the Securities and Exchange Commission (the &#8220;<span style="font-style:italic;font-weight:bold;">SEC</span>&#8221;) on April 26, 2024 (the &#8220;<span style="font-style:italic;font-weight:bold;">Proxy Statement</span>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The foregoing description of the Plan Amendment does not purport to be complete and is qualified in its entirety by reference to the complete text of the Plan Amendment. The Plan Amendment has been incorporated into the 2022 Plan via an Amended and Restated MaxCyte, Inc. 2022 Equity Incentive Plan (the &#8220;<span style="font-style:italic;font-weight:bold;">Amended and Restated 2022 Plan</span>&#8221;), which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:22.5pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><a id="_8e0d7599_58c5_460d_a3c9_0450e20a0a70"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Item 5.07. Submission of Matters to a Vote of Security Holders.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_Hlk165888311"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">During the Annual Meeting, the Company&#8217;s stockholders considered three proposals, each of which is described in more detail in the Proxy Statement. Set forth below are the results of the matters submitted for a vote of stockholders at the Annual Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Proposal 1 - Election of directors:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Nominee</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Withhold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Broker&#160;Non-Votes</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Will Brooke</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">68,727,229</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,026,170</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">12,060,733</p></td></tr><tr><td style="vertical-align:bottom;width:62.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">John Johnston</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">68,991,928</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">761,471</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">12,060,733</p></td></tr><tr><td style="vertical-align:bottom;width:62.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Richard Douglas</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">48,055,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">21,698,036</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">12,060,733</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Proposal 2 - Approval of the Plan Amendment:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:37.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Votes For</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Votes&#160;Against</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Abstentions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Broker&#160;Non-Votes</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.49%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">58,665,618</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.75%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">10,758,144</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">329,637</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.76%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">12,060,733</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Proposal 3 - Ratification of appointment of CohnReznick LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:37.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Votes For</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Votes&#160;Against</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Abstentions</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.02%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">81,711,923</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.66%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">7,327</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">94,882</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><a id="_28573d1b_6ff6_484d_84d8_e21005f82f18"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Item&#160;9.01. Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(d)&#160;Exhibits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exhibit No.</b></p></td><td style="vertical-align:top;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:86.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Description </b></p></td></tr><tr><td style="vertical-align:bottom;width:10.22%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.1</p></td><td style="vertical-align:top;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:86.91%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mxct-20240611xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Amended and Restated 2022 Plan</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:10.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">104</p></td><td style="vertical-align:top;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:86.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL Document)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_9344b776_a32d_437e_a79c_b658fd725a11"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MaxCyte, Inc.</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;"> Date: June 12, 2024</span></p></td><td style="vertical-align:bottom;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Douglas Swirsky</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:46%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Douglas Swirsky</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>mxct-20240611xex10d1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.125.0--><!--Created on: 6/12/2024 03:21:51 AM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Exhibit 10.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">MAXCYTE, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">2022 EQUITY INCENTIVE PLAN</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Amended and Restated: June 11, 2024</b></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">1.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">GENERAL.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></font><b style="font-weight:bold;">Defined Terms. </b>Except as otherwise provided, any capitalized term shall have the meaning provided in Section 14 of this Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><b style="font-weight:bold;">(b)&#160;&#160;&#160;Successor to and Continuation of Prior Plan. </b>The Plan is the successor to and continuation of the Prior Plan. As of the Effective Date, (i) no additional awards may be granted under the Prior Plan or the Inducement Plan; (ii) the Prior Plan&#8217;s Available Reserve (plus any Prior Plans&#8217; Returning Shares) will become available for issuance pursuant to Awards granted under this Plan; (iii) all outstanding awards granted under the Prior Plan will remain subject to the terms of the Prior Plan; and (iv) all outstanding awards granted under the Inducement Plan will remain subject to the terms of the Inducement Plan. All Awards granted under this Plan will be subject to the terms of this Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></font><b style="font-weight:bold;">Plan Purpose. </b>The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such persons may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></font><b style="font-weight:bold;">Available Awards. </b>The Plan provides for the grant of the following Awards: (i) Incentive Stock Options; (ii) Nonstatutory Stock Options; (iii) SARs; (iv) Restricted Stock Awards; (v) RSU Awards; (vi) Performance Awards; and (vii) Other Awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(e)</b></font><b style="font-weight:bold;">Adoption Date; Effective Date. </b>The Plan will come into existence on the Adoption Date, but no Award may be granted prior to the Effective Date.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">2.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">SHARES SUBJECT TO THE PLAN.</b></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.45pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(a)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><font style="font-style:italic;font-weight:bold;">Share Reserve.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(i)&#160;&#160;&#160;</b>Subject to adjustment in accordance with Section 2(c) and any adjustments as necessary to implement any Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Awards will not exceed the sum of: (i) 2,300,000 new shares, plus (ii) the 7,997,000 shares previously approved under the Plan, plus (iii) a number of shares of Common Stock equal to the Prior Plan&#8217;s Available Reserve, plus (iv) a number of shares of Common Stock equal to the number of Prior Plan&#8217;s Returning Shares, if any, as such shares become available from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(ii)&#160;&#160;</b>Subject to Section 2(c), the number of shares of Common Stock available for issuance under the Plan will be reduced by: (A) one share for each share of Common Stock issued pursuant to an Appreciation Award granted under the Plan; and (B) 1.14 shares for each share of Common Stock issued pursuant to a Full Value Award granted under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(iii)&#160;</b>Subject to Section 2(c), the number of shares of Common Stock available for issuance under the Plan will be increased by: (A) one share for each Prior Plans&#8217; Returning Share or 2022 Plan Returning Share (as defined in Section 2(c)(iii)) subject to an Appreciation Award; and (B) 1.14 shares for each Prior Plans&#8217; Returning Share or 2022 Plan Returning Share subject to a Full Value Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></font><b style="font-weight:bold;">Aggregate Incentive Stock Option Limit. </b>Notwithstanding anything to the contrary in Section 2(a) and subject to any adjustments as necessary to implement any Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options is 37,200,000 shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.45pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(c)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><font style="font-style:italic;font-weight:bold;">Share Reserve Operation.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font><b style="font-weight:bold;">Limit Applies to Common Stock Issued Pursuant to Awards. </b>For clarity, the Share Reserve is a limit on the number of shares of Common Stock that may be issued pursuant to Awards and does not limit the granting of Awards, except that the Company will keep available at all times the number of shares of Common Stock reasonably required to satisfy its obligations to issue shares pursuant to such Awards. Shares may be issued in connection with a merger or acquisition as permitted by, as applicable, Nasdaq Listing Rule 5635(c), NYSE Listed Company Manual Section 303A.08, NYSE American Company Guide Section 711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font><b style="font-weight:bold;">Actions that Do Not Constitute Issuance of Common Stock and Do Not Reduce Share Reserve. </b>The following actions do not result in an issuance of shares under the Plan and accordingly do not reduce the number of shares subject to the Share Reserve and available for issuance under the Plan: (1) the expiration or termination of any portion of an Award without the shares covered by such portion of the Award having been issued; or (2) the settlement of any portion of an Award in cash (i.e., the Participant receives cash rather than shares of Common Stock).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iii)</b></font><b style="font-weight:bold;">Previously Issued Shares of Common Stock Available for Subsequent Issuance. </b>The following shares of Common Stock (collectively, the &#8220;<font style="font-style:italic;font-weight:bold;">2022 Plan Returning Shares</font>&#8221;) previously issued pursuant to an Award will become available again for issuance under the Plan: any shares that are forfeited back to or repurchased by the Company because of a failure to meet a contingency or condition required for the vesting of such shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iv)</b></font><b style="font-weight:bold;">Previously Issued Shares of Common Stock Not Available for Subsequent Issuance. </b>The following shares of Common Stock previously issued pursuant to an Award will not become available again for issuance under the Plan: (1) any shares that are reacquired or withheld (or not issued) by the Company to satisfy (i) the exercise or strike price of an Appreciation Award or (ii) the purchase price of a Full Value Award; (2) any shares that are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with an Appreciation Award or a Full Value Award; (3) any shares repurchased by the Company on the open market with the proceeds of (i) the exercise or strike price of an Appreciation Award or (ii) the purchase price of a Full Value Award; and (4) in the event that an SAR is settled in shares of Common Stock, the gross number of shares of Common Stock subject to such award.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">3.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">ELIGIBILITY AND LIMITATIONS.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></font><b style="font-weight:bold;">Eligible Award Recipients. </b>Subject to the terms of the Plan, Employees, Directors and Consultants are eligible to receive Awards.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.45pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(b)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><font style="font-style:italic;font-weight:bold;">Specific Award Limitations.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.25pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font><b style="font-weight:bold;">Limitations on Incentive Stock Option Recipients. </b>Incentive Stock Options may be granted only to Employees of the Company or a &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections 424(e) and (f) of the Code).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font><b style="font-weight:bold;">Incentive Stock Option $100,000 Limitation. </b>To the extent that the aggregate fair market value (determined at the time of grant) of the shares of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; thereof, as such terms are defined in Sections 424(e) and (f) of the Code) exceeds $100,000 (or such other limit established in the Code), or any Incentive Stock Options otherwise do not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iii)</b></font><b style="font-weight:bold;">Limitations on Incentive Stock Options Granted to Ten Percent Stockholders. </b>A Ten Percent Stockholder may not be granted an Incentive Stock Option unless (i) the exercise price of such Option is at least 110% of the Fair Market Value on the date of grant of such Option and (ii) the Option is not exercisable after the expiration of five years from the date of grant of such Option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iv)</b></font><b style="font-weight:bold;">Limitations on Nonstatutory Stock Options and SARs. </b>Nonstatutory Stock Options and SARs may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#8220;parent&#8221; of the Company (as such term is defined in Rule 405) unless the stock underlying such Awards is treated as &#8220;service recipient stock&#8221; under Section 409A because the Awards are granted pursuant to a corporate transaction (such as a spin off transaction) or unless such Awards otherwise comply with the distribution requirements of Section 409A.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></font><b style="font-weight:bold;">Aggregate Incentive Stock Option Limit. </b>The aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options is the number of shares specified in Section 2(b).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></font><b style="font-weight:bold;">Non-Employee Director Compensation Limit. </b>The aggregate value of all compensation granted or paid, as applicable, to any individual for service as a Non-Employee Director with respect to any fiscal year, including Awards granted and cash fees paid by the Company to such Non-Employee Director for his or her service as a Non-Employee Director, will not exceed (i) $900,000 in total value or (ii) in the event such Non-Employee Director is first appointed or elected to the Board during such fiscal year, $1,400,000 in total value, in each case calculating the value of any equity awards based on the grant date fair value of such equity awards for financial reporting purposes.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">4.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">OPTIONS AND STOCK APPRECIATION RIGHTS.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Each Option and SAR will have such terms and conditions as determined by the Board. Each Option will be designated in writing as an Incentive Stock Option or Nonstatutory Stock Option at the time of grant; provided, however, that if an Option is not so designated, then such Option will be a Nonstatutory Stock Option, and the shares purchased upon exercise of each type of Option will be separately accounted for. Each SAR will be denominated in shares of Common Stock equivalents. The terms and conditions of separate Options and SARs need not be identical; provided, however, that each Option Agreement and SAR Agreement will conform (through incorporation of provisions hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></font><b style="font-weight:bold;">Term. </b>Subject to Section 3(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the expiration of ten years from the date of grant of such Award or such shorter period specified in the Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></font><b style="font-weight:bold;">Exercise or Strike Price. </b>Subject to Section 3(b) regarding Ten Percent Stockholders, the exercise or strike price of each Option or SAR will not be less than 100% of the Fair Market Value on the date of grant of such Award. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair Market Value on the date of grant of such Award if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Transaction and in a manner consistent with the provisions of Sections 409A and, if applicable, 424(a) of the Code.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></font><b style="font-weight:bold;">Exercise Procedure and Payment of Exercise Price for Options. </b>In order to exercise an Option, the Participant must provide notice of exercise to the Plan Administrator in accordance with the procedures specified in the Option Agreement or otherwise provided by the Company. The Board has the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to utilize a particular method of payment. The exercise price of an Option may be paid, to the extent permitted by Applicable Law and as determined by the Board, by one or more of the following methods of payment to the extent set forth in the Option Agreement:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.25pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font>by cash or check, bank draft or money order payable to the Company;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font>pursuant to a &#8220;cashless exercise&#8221; program developed under Regulation T as promulgated by the United States Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the exercise price to the Company from the sales proceeds;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.05pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iii)</b></font>by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock that are already owned by the Participant free and clear of any liens, claims, encumbrances or security interests, with a Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (1) at the time of exercise the Common Stock is publicly traded, (2) any remaining balance of the exercise price not satisfied by such delivery is</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">paid by the Participant in cash or other permitted form of payment, (3) such delivery would not violate any Applicable Law or agreement restricting the redemption of the Common Stock, (4) any certificated shares are endorsed or accompanied by an executed assignment separate from certificate, and (5) such shares have been held by the Participant for any minimum period necessary to avoid adverse accounting treatment as a result of such delivery;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iv)</b></font>if the Option is a Nonstatutory Stock Option, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (1) such shares used to pay the exercise price will not be exercisable thereafter and (2) any remaining balance of the exercise price not satisfied by such net exercise is paid by the Participant in cash or other permitted form of payment; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(v)</b></font>in any other form of consideration that may be acceptable to the Board and permissible under Applicable Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></font><b style="font-weight:bold;">Exercise Procedure and Payment of Appreciation Distribution for SARs. </b>In order to exercise any SAR, the Participant must provide notice of exercise to the Plan Administrator in accordance with the SAR Agreement. The appreciation distribution payable to a Participant upon the exercise of a SAR will not be greater than an amount equal to the excess of (i) the aggregate Fair Market Value on the date of exercise of a number of shares of Common Stock equal to the number of Common Stock equivalents that are vested and being exercised under such SAR, over (ii) the strike price of such SAR. Such appreciation distribution may be paid to the Participant in the form of Common Stock or cash (or any combination of Common Stock and cash) or in any other form of payment, as determined by the Board and specified in the SAR Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(e)</b></font><b style="font-weight:bold;">Transferability. </b>Options and SARs may not be transferred to third party financial institutions for value. The Board may impose such additional limitations on the transferability of an Option or SAR as it determines. In the absence of any such determination by the Board, the following restrictions on the transferability of Options and SARs will apply, provided that except as explicitly provided herein, neither an Option nor a SAR may be transferred for consideration and provided, further, that if an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of being transferred:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font><b style="font-weight:bold;">Restrictions on Transfer. </b>An Option or SAR will not be transferable, except by will or by the laws of descent and distribution, and will be exercisable during the lifetime of the Participant only by the Participant; provided, however, that the Board may permit transfer of an Option or SAR in a manner that is not prohibited by applicable tax and securities laws upon the Participant&#8217;s request, including to a trust if the Participant is considered to be the sole beneficial owner of such trust (as determined under Section 671 of the Code and applicable U.S. state law) while such Option or SAR is held in such trust, provided that the Participant and the trustee enter into a transfer and other agreements required by the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font><b style="font-weight:bold;">Domestic Relations Orders. </b>Notwithstanding the foregoing, subject to the execution of transfer documentation in a format acceptable to the Company and subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to a domestic relations order.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(f)</b></font><b style="font-weight:bold;">Vesting. </b>The Board may impose such restrictions on or conditions to the vesting and/or exercisability of an Option or SAR as determined by the Board. Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, vesting of Options and SARs will cease upon termination of the Participant&#8217;s Continuous Service.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(g)</b></font><b style="font-weight:bold;">Termination of Continuous Service for Cause. </b>Except as explicitly otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service is terminated for Cause, the Participant&#8217;s Options and SARs will terminate and be forfeited immediately upon such termination of Continuous Service, and the Participant will be prohibited from exercising any portion (including any vested portion) of such Awards on and after the date of such termination of Continuous Service and the Participant will have no further right, title or interest in such forfeited Award, the shares of Common Stock subject to the forfeited Award, or any consideration in respect of the forfeited Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(h)</b></font><b style="font-weight:bold;">Post-Termination Exercise Period Following Termination of Continuous Service for Reasons Other than Cause. </b>Subject to Section 4(i), if a Participant&#8217;s Continuous Service terminates for any reason other than for Cause, the Participant may exercise his or her Option or SAR to the extent vested, but only within the following period of time or, if applicable, such other period of time provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate; provided, however, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in Section 4(a)):</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18.7pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(i)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">three months following the date of such termination if such termination is a termination without Cause (other than any termination due to the Participant&#8217;s Disability or death);</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18.7pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(ii)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">12 months following the date of such termination if such termination is due to the Participant&#8217;s Disability;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18.7pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(iii)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">18 months following the date of such termination if such termination is due to the Participant&#8217;s death; or</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18.7pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(iv)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">18 months following the date of the Participant&#8217;s death if such death occurs following the date of such termination but during the period such Award is otherwise exercisable (as provided in (i) or (ii) above).</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 3.25pt;">Following the date of such termination, to the extent the Participant does not exercise such Award within the applicable Post-Termination Exercise Period (or, if earlier, prior to the expiration of the maximum term of such Award), such unexercised portion of the Award will terminate, and the Participant will have no further right, title or interest in terminated Award, the shares of Common Stock subject to the terminated Award, or any consideration in respect of the terminated Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font><b style="font-weight:bold;">Restrictions on Exercise; Extension of Exercisability. </b>A Participant may not exercise an Option or SAR at any time that the issuance of shares of Common Stock upon such exercise would violate Applicable Law. Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates for any reason other than for Cause and, at any time during the last thirty days of the applicable Post-Termination Exercise Period, the exercise of the Participant&#8217;s Option or SAR would be prohibited solely because the issuance of shares of Common Stock upon such exercise would violate Applicable Law (as determined in the sole discretion of the Board), then the applicable Post-Termination Exercise Period will be extended to the last day of the calendar month that commences following the date the Award would otherwise expire, with an additional extension of the exercise period to the last day of the next calendar month to apply if any of the foregoing restrictions apply at any time during such extended exercise period, generally without limitation as to the maximum permitted number of extensions; provided, however, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in Section 4(a)).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(j)</b></font><b style="font-weight:bold;">Non-Exempt Employees</b>. No Option or SAR, whether or not vested, granted to an Employee who is a non-exempt employee for purposes of the United States Fair Labor Standards Act of 1938, as amended, will be first exercisable for any shares of Common Stock until at least six months following the date of grant of such Award. Notwithstanding the foregoing, in accordance with the provisions of the United States Worker Economic Opportunity Act, any vested portion of such Award may be exercised earlier than six months following the date of grant of such Award in the event of (i) such Participant&#8217;s death or Disability, (ii) a Transaction in which such Award is not assumed, continued or substituted, (iii) a Change in Control, or (iv) such Participant&#8217;s retirement (as such term may be defined in the Award Agreement or another applicable agreement or, in the absence of any such definition, in accordance with the Company&#8217;s then current employment policies and guidelines). This Section 4(j) is intended to operate so that any income derived by a non- exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(k)</b></font><b style="font-weight:bold;">Whole Shares. </b>Options and SARs may be exercised only with respect to whole shares of Common Stock or their equivalents.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">5.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">AWARDS OTHER THAN OPTIONS AND STOCK APPRECIATION RIGHTS.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></font><b style="font-weight:bold;">Restricted Stock Awards and RSU Awards. </b>Each Restricted Stock Award and RSU Award will have such terms and conditions as determined by the Board; provided, however, that each Restricted Stock Award Agreement and RSU Award Agreement will conform (through incorporation of the provisions hereof by reference in the Award</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Agreement or otherwise) to the substance of each of the following provisions:</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18.7pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">(i)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-style:italic;font-weight:bold;">Form of Award.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:54pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(1)&#160;&#160;&#160;</b>RSAs: To the extent consistent with the Company&#8217;s Bylaws, at the Board&#8217;s election, shares of Common Stock subject to a Restricted Stock Award may be (i) held in book entry form subject to the Company&#8217;s instructions until such shares become vested or any other restrictions lapse, or (ii) evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board. Unless otherwise determined by the Board, a Participant will have voting and other rights as a stockholder of the Company with respect to any shares subject to a Restricted Stock Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:54pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(2)&#160;&#160;&#160;</b>RSUs: A RSU Award represents a Participant&#8217;s right to be issued on a future date the number of shares of Common Stock that is equal to the number of restricted stock units subject to the RSU Award. As a holder of a RSU Award, a Participant is an unsecured creditor of the Company with respect to the Company&#8217;s unfunded obligation, if any, to issue shares of Common Stock in settlement of such Award and nothing contained in the Plan or any RSU Agreement, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between a Participant and the Company or an Affiliate or any other person. A Participant will not have voting or any other rights as a stockholder of the Company with respect to any RSU Award (unless and until shares are actually issued in settlement of a vested RSU Award).</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18.7pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">(ii)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-style:italic;font-weight:bold;">Consideration.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:54pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(1)&#160;&#160;&#160;</b>RSA: A Restricted Stock Award may be granted in consideration for (A) cash or check, bank draft or money order payable to the Company, (B) past services to the Company or an Affiliate, or (C) any other form of consideration as the Board may determine and permissible under Applicable Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:54pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(2)&#160;&#160;&#160;</b>RSU: Unless otherwise determined by the Board at the time of grant, a RSU Award will be granted in consideration for the Participant&#8217;s services to the Company or an Affiliate, such that the Participant will not be required to make any payment to the Company (other than such services) with respect to the grant or vesting of the RSU Award, or the issuance of any shares of Common Stock pursuant to the RSU Award. If, at the time of grant, the Board determines that any consideration must be paid by the Participant (in a form other than the Participant&#8217;s services to the Company or an Affiliate) upon the issuance of any shares of Common Stock in settlement of the RSU Award, such consideration may be paid in any form of consideration as the Board may determine and permissible under Applicable Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.1pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iii)</b></font><b style="font-weight:bold;">Vesting. </b>The Board may impose such restrictions on or conditions to the vesting of a Restricted Stock Award or RSU Award as determined by the Board. Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, vesting of Restricted Stock Awards and RSU Awards will cease upon termination of the Participant&#8217;s Continuous Service.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.85pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iv)</b></font><b style="font-weight:bold;">Termination of Continuous Service. </b>Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates for any reason, (i) the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant under his or her Restricted Stock Award that have not vested as of the date of such termination as set forth in the Restricted Stock Award Agreement and (ii) any portion of his or her RSU Award that has not vested will be forfeited upon such termination and the Participant will have no further right, title or interest in the RSU Award, the shares of Common Stock issuable pursuant to the RSU Award, or any consideration in respect of the RSU Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.45pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(v)</b></font><b style="font-weight:bold;">Settlement of RSU Awards</b>. A RSU Award may be settled by the issuance of shares of Common Stock or cash (or any combination thereof) or in any other form of payment, as determined by the Board and specified in the RSU Award Agreement. At the time of grant, the Board may determine to impose such restrictions or conditions that delay such delivery to a date following the vesting of the RSU Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></font><b style="font-weight:bold;">Performance Awards</b>. With respect to any Performance Award, the length of any Performance Period, the Performance Goals to be achieved during the Performance Period, the other terms and conditions of such Award, and the measure of whether and to what degree such Performance Goals have been attained will be determined by the</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></font><b style="font-weight:bold;">Other Awards</b>. Other Awards may be granted either alone or in addition to Awards provided for under Section 4 and the preceding provisions of this Section 5. Subject to the provisions of the Plan, the Board will have sole and complete discretion to determine the persons to whom and the time or times at which such Other Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Awards and all other terms and conditions of such Other Awards.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">6.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">ADJUSTMENTS UPON CHANGES IN COMMON STOCK; OTHER CORPORATE EVENTS.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></font><b style="font-weight:bold;">Capitalization Adjustments</b>. In the event of a Capitalization Adjustment, the Board shall appropriately and proportionately adjust: (i) the class(es) and maximum number of shares of Common Stock subject to the Plan and the maximum number of shares by which the Share Reserve may annually increase pursuant to Section 2(a), (ii) the class(es) and maximum number of shares that may be issued pursuant to the exercise of Incentive Stock Options pursuant to Section 2(b), and (iii) the class(es) and number of securities and exercise price, strike price or purchase price of Common Stock subject to outstanding Awards. The Board shall make such adjustments, and its determination shall be final, binding and conclusive. Notwithstanding the foregoing, no fractional shares or rights for fractional shares of Common Stock shall be created in order to implement any Capitalization Adjustment. The Board shall determine an appropriate equivalent benefit, if any, for any fractional shares or rights to fractional shares that might be created by the adjustments referred to in the preceding provisions of this Section.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></font><b style="font-weight:bold;">Dissolution or Liquidation</b>. Except as otherwise provided in the Award Agreement, in the event of a dissolution or liquidation of the Company, all outstanding Awards (other than Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the shares of Common Stock subject to the Company&#8217;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Award is providing Continuous Service, provided, however, that the Board may determine to cause some or all Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent on its completion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></font><b style="font-weight:bold;">Transactions. </b>The following provisions will apply to Awards in the event of a Transaction except as set forth in Section 11, and unless otherwise provided in the instrument evidencing the Award or any other written agreement between the Company or any Affiliate and the Participant or in a director compensation policy or unless otherwise expressly provided by the Board at the time of grant of an Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font><b style="font-weight:bold;">Awards May Be Assumed. </b>In the event of a Transaction, any surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) may assume or continue any or all Awards outstanding under the Plan or may substitute similar awards for Awards outstanding under the Plan (including but not limited to, awards to acquire the same consideration paid to the stockholders of the Company pursuant to the Transaction), and any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to Awards may be assigned by the Company to the successor of the Company (or the successor&#8217;s parent company, if any), in connection with such Transaction. A surviving corporation or acquiring corporation (or its parent) may choose to assume or continue only a portion of an Award or substitute a similar award for only a portion of an Award, or may choose to assume, continue, or substitute the Awards held by some, but not all Participants. The terms of any assumption, continuation or substitution will be set by the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font><b style="font-weight:bold;">Awards Held by Current Participants. </b>In the event of a Transaction in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding Awards or substitute similar awards for such outstanding Awards, then with respect to Awards that have not been assumed, continued or substituted and that are held by Participants whose Continuous Service has not terminated prior to the effective time of the Transaction (referred to as the &#8220;<b style="font-weight:bold;">Current Participants</b>&#8221;), the vesting of such Awards (and, with respect to Options and SARs, the time when such Awards may be exercised) will be accelerated in full to a date prior to the effective time of such Transaction (contingent upon the effectiveness of the Transaction) as the Board determines (or, if the Board does not determine such a date, to the date that is five days prior to the effective time of the Transaction), and such Awards will terminate if not exercised (if applicable) at or prior to the effective time of the Transaction, and any reacquisition or repurchase rights held by the Company with respect to such Awards will lapse (contingent upon the</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">effectiveness of the Transaction). With respect to the vesting of Performance Awards that will accelerate upon the occurrence of a Transaction pursuant to this subsection (ii) and that have multiple vesting levels depending on the level of performance, unless otherwise provided in the Award Agreement, the vesting of such Performance Awards will accelerate at 100% of the target level upon the occurrence of the Transaction. With respect to the vesting of Awards that will accelerate upon the occurrence of a Transaction pursuant to this subsection (ii) and are settled in the form of a cash payment, such cash payment will be made no later than 30 days following the occurrence of the Transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.05pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iii)</b></font><b style="font-weight:bold;">Awards Held by Persons other than Current Participants. </b>In the event of a Transaction in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding Awards or substitute similar awards for such outstanding Awards, then with respect to Awards that have not been assumed, continued or substituted and that are held by persons other than Current Participants, such Awards will terminate if not exercised (if applicable) prior to the occurrence of the Transaction; provided, however, that any reacquisition or repurchase rights held by the Company with respect to such Awards will not terminate and may continue to be exercised notwithstanding the Transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iv)</b></font><b style="font-weight:bold;">Payment for Awards in Lieu of Exercise. </b>Notwithstanding the foregoing, in the event an Award will terminate if not exercised prior to the effective time of a Transaction, the Board may provide, in its sole discretion, that the holder of such Award may not exercise such Award but will receive a payment, in such form as may be determined by the Board, equal in value, at the effective time, to the excess, if any, of (1) the value of the property the Participant would have received upon the exercise of the Award (including, at the discretion of the Board, any unvested portion of such Award), over (2) any exercise price payable by such holder in connection with such exercise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></font><b style="font-weight:bold;">Appointment of Stockholder Representative. </b>As a condition to the receipt of an Award under this Plan, a Participant will be deemed to have agreed that the Award will be subject to the terms of any agreement governing a Transaction involving the Company, including, without limitation, a provision for the appointment of a stockholder representative that is authorized to act on the Participant&#8217;s behalf with respect to any escrow, indemnities and any contingent consideration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(e)</b></font><b style="font-weight:bold;">No Restriction on Right to Undertake Transactions</b>. The grant of any Award under the Plan and the issuance of shares pursuant to any Award does not affect or restrict in any way the right or power of the Company or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company&#8217;s capital structure or its business, any merger or consolidation of the Company, any issue of stock or of options, rights or options to purchase stock or of bonds, debentures, preferred or prior preference stocks whose rights are superior to or affect the Common Stock or the rights thereof or which are convertible into or exchangeable for Common Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether of a similar character or otherwise.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">7.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">ADMINISTRATION.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></font><b style="font-weight:bold;">Administration by Board. </b>The Board will administer the Plan unless and until the Board delegates administration of the Plan to a Committee or Committees, as provided in subsection (c) below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></font><b style="font-weight:bold;">Powers of Board. </b>The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font>To determine from time to time: (1) which of the persons eligible under the Plan will be granted Awards; (2) when and how each Award will be granted; (3) what type or combination of types of Award will be granted; (4) the provisions of each Award granted (which need not be identical), including the time or times when a person will be permitted to receive an issuance of Common Stock or other payment pursuant to an Award; (5) the number of shares of Common Stock or cash equivalent with respect to which an Award will be granted to each such person; (6) the Fair Market Value applicable to an Award; and (7) the terms of any Performance Award that is not valued in whole or in part by reference to, or otherwise based on, the Common Stock, including the amount of cash payment or other property that may be earned and the timing of payment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font>To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement, in a manner and to the extent it deems necessary or expedient</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">to make the Plan or Award fully effective.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.15pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iii)</b></font>To settle all controversies regarding the Plan and Awards granted under it.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.85pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iv)</b></font>To accelerate the time at which an Award may first be exercised or the time during which an Award or any part thereof will vest, notwithstanding the provisions in the Award Agreement stating the time at which it may first be exercised or the time during which it will vest.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.45pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(v)</b></font>To prohibit the exercise of any Option, SAR or other exercisable Award during a period of up to 30 days prior to the consummation of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other change affecting the shares of Common Stock or the share price of the Common Stock (including, but not limited to, any Transaction), for reasons of administrative convenience.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.9pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(vi)</b></font>To suspend or terminate the Plan at any time. Suspension or termination of the Plan will not Materially Impair rights and obligations under any Award granted while the Plan is in effect except with the written consent of the affected Participant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.05pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(vii)</b></font>To amend the Plan in any respect the Board deems necessary or advisable; provided, however, that stockholder approval will be required for any amendment to the extent required by Applicable Law. Except as provided above, rights under any Award granted before amendment of the Plan will not be Materially Impaired by any amendment of the Plan unless (1) the Company requests the consent of the affected Participant, and (2) such Participant consents in writing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(viii)</b></font>To submit any amendment to the Plan for stockholder approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.85pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ix)</b></font>To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; provided however, that, a Participant&#8217;s rights under any Award will not be Materially Impaired by any such amendment unless (1) the Company requests the consent of the affected Participant, and (2) such Participant consents in writing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(x)</b></font>Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.85pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(xi)</b></font>To adopt such procedures and sub-plans as are necessary or appropriate to permit and facilitate participation in the Plan by, or take advantage of specific tax treatment for Awards granted to, Employees, Directors or Consultants who are non-U.S. nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award Agreement to ensure or facilitate compliance with the laws of the relevant non-U.S. jurisdiction).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></font><font style="font-style:italic;font-weight:bold;">Delegation to Committee.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.9pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font><b style="font-weight:bold;">General. </b>The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to another Committee or a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. Each Committee may retain the authority to concurrently administer the Plan with the Committee or subcommittee to which it has delegated its authority hereunder and may, at any time, revest in such Committee some or all of the powers previously delegated. The Board may retain the authority to concurrently administer the Plan with any Committee and may, at any time, revest in the Board some or all of the powers previously delegated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.9pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font><b style="font-weight:bold;">Rule 16b-3 Compliance. </b>To the extent an Award is intended to qualify for the exemption from Section 16(b) of the Exchange Act that is available under Rule 16b-3 of the Exchange Act, the Award will be granted by the Board or a Committee that consists solely of two or more Non-Employee Directors, as determined under Rule 16b-3(b)(3) of the Exchange Act and thereafter any action establishing or modifying the terms of the Award will be approved by the Board or a Committee meeting such requirements to the extent necessary for such exemption to remain available.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></font><b style="font-weight:bold;">Effect of Board&#8217;s Decision. </b>All determinations, interpretations and constructions made by the Board or any Committee in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(e)</b></font><b style="font-weight:bold;">Delegation to an Officer. </b>The Board or any Committee may delegate to one or more Officers the authority to do one or both of the following (i) designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by Applicable Law, other types of Awards) and, to the extent permitted by Applicable Law, the terms thereof, and (ii) determine the number of shares of Common Stock to be subject to such Awards granted to such Employees; provided, however, that the resolutions or charter adopted by the Board or any Committee evidencing such delegation will specify the total number of shares of Common Stock that may be subject to the Awards granted by such Officer and that such Officer may not grant an Award to himself or herself. Any such Awards will be granted on the applicable form of Award Agreement most recently approved for use by the Board or the Committee, unless otherwise provided in the resolutions approving the delegation authority. Notwithstanding anything to the contrary herein, neither the Board nor any Committee may delegate to an Officer who is acting solely in the capacity of an Officer (and not also as a Director) the authority to determine the Fair Market Value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(f)</b></font><b style="font-weight:bold;">No Repricing Without Stockholder Approval. </b>Neither the Board nor any Committee shall have the authority to: (1) reduce the exercise price (or strike price) of any outstanding Option or SAR; (2) cancel any outstanding Option or SAR and grant in substitution therefor (A) a new Option, SAR, Restricted Stock Award, RSU Award or Other Award, under the Plan or another equity plan of the Company, covering the same or a different number of shares of Common Stock, (B) cash and/or (C) other valuable consideration (as determined by the Board or any Committee); or (3) take any other action that is treated as a repricing under generally accepted accounting principles, unless the stockholders of the Company have approved such an action within the prior twelve (12) months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(g)</b></font><b style="font-weight:bold;">Minimum Vesting Requirements</b>. Notwithstanding any other provision of the Plan, no Award may vest (and/or, if applicable, be exercisable) until at least twelve (12) months following the date of grant of the Award; provided, however, that up to five percent (5%) of the Share Reserve may be subject to Awards that do not meet such vesting (and/or, if applicable, exercisability) requirements.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">8.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">TAX WITHHOLDING</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></font><b style="font-weight:bold;">Withholding Authorization. </b>As a condition to acceptance of any Award under the Plan, a Participant authorizes withholding from payroll and any other amounts payable to such Participant, and otherwise agrees to make adequate provision for, any sums required to satisfy any U.S. and/or non-U.S. federal, state or local tax or social insurance contribution withholding obligations of the Company or an Affiliate, if any, which arise in connection with the grant, vesting, exercise, or settlement of such Award, as applicable. Accordingly, a Participant may not be able to exercise an Award even though the Award is vested, and the Company shall have no obligation to issue shares of Common Stock subject to an Award, unless and until such obligations are satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></font><b style="font-weight:bold;">Satisfaction of Withholding Obligation. </b>To the extent permitted by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any U.S. and/or non-U.S. federal, state or local tax or social insurance withholding obligation relating to an Award by any of the following means or by a combination of such means: (i) causing the Participant to tender a cash payment; (ii) withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Award; (iii) withholding cash from an Award settled in cash; (iv) withholding payment from any amounts otherwise payable to the Participant; (v) by allowing a Participant to effectuate a &#8220;cashless exercise&#8221; pursuant to a program developed under Regulation T as promulgated by the United States Federal Reserve Board; or (vi) by such other method as may be set forth in the Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></font><b style="font-weight:bold;">No Obligation to Notify or Minimize Taxes; No Liability to Claims. </b>Except as required by Applicable Law, the Company has no duty or obligation to any Participant to advise such holder as to the time or manner of exercising such Award. Furthermore, the Company has no duty or obligation to warn or otherwise advise such holder</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award and will not be liable to any holder of an Award for any adverse tax consequences to such holder in connection with an Award. As a condition to accepting an Award under the Plan, each Participant (i) agrees to not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from such Award or other Company compensation and (ii) acknowledges that such Participant was advised to consult with his or her own personal tax, financial and other legal advisors regarding the tax consequences of the Award and has either done so or knowingly and voluntarily declined to do so. Additionally, each Participant acknowledges any Option or SAR granted under the Plan is exempt from Section 409A only if the exercise or strike price is at least equal to the &#8220;fair market value&#8221; of the Common Stock on the date of grant as determined by the United States Internal Revenue Service and there is no other impermissible deferral of compensation associated with the Award. Additionally, as a condition to accepting an Option or SAR granted under the Plan, each Participant agrees not to make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates in the event that the United States Internal Revenue Service asserts that such exercise price or strike price is less than the &#8220;fair market value&#8221; of the Common Stock on the date of grant as subsequently determined by the United States Internal Revenue Service.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></font><b style="font-weight:bold;">Withholding Indemnification. </b>As a condition to accepting an Award under the Plan, in the event that the amount of the Company&#8217;s and/or its Affiliate&#8217;s withholding obligation in connection with such Award was greater than the amount actually withheld by the Company and/or its Affiliates, each Participant agrees to indemnify and hold the Company and/or its Affiliates harmless from any failure by the Company and/or its Affiliates to withhold the proper amount.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">9.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">MISCELLANEOUS.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></font><font style="font-style:italic;font-weight:bold;">Dividends and Dividend Equivalents.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.9pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font>Dividends or dividend equivalents may not be paid or credited to Options or SARs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.9pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font>With respect to any Award other than an Option or SAR, dividends or dividend equivalents may be paid or credited, as applicable, with respect to any shares of Common Stock subject to such Award, as determined by the Board and specified in the applicable Award Agreement; provided, however, that (i) no dividends or dividend equivalents may be paid or settled <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">with respect to any such shares</u> before the date <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">such shares</u> have vested under the terms of such Award Agreement; (ii) any dividends or dividend equivalents that are credited with respect to any such shares shall be subject to all of the terms and conditions applicable to such shares under the terms of such Award Agreement (including, but not limited to, any vesting conditions); and (iii) any dividends or dividend equivalents that are credited with respect to any such shares shall be forfeited to the Company on the date, if any, such shares are forfeited to or repurchased by the Company due to a failure to meet any vesting conditions under the terms of such Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></font><b style="font-weight:bold;">Source of Shares. </b>The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></font><b style="font-weight:bold;">Use of Proceeds from Sales of Common Stock. </b>Proceeds from the sale of shares of Common Stock pursuant to Awards will constitute general funds of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></font><b style="font-weight:bold;">Corporate Action Constituting Grant of Awards. </b>Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action approving the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(e)</b></font><b style="font-weight:bold;">Stockholder Rights. </b>No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to such Award unless and until (i) such Participant has satisfied</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">all requirements for exercise of the Award pursuant to its terms, if applicable, and (ii) the issuance of the Common Stock subject to such Award is reflected in the records of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(f)</b></font><b style="font-weight:bold;">No Employment or Other Service Rights. </b>Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or affect the right of the Company or an Affiliate to terminate at will and without regard to any future vesting opportunity that a Participant may have with respect to any Award (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the terms of such Consultant&#8217;s agreement with the Company or an Affiliate, or (iii) the service of a Director pursuant to the Bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the U.S. state or non-U.S. jurisdiction in which the Company or the Affiliate is incorporated, as the case may be. Further, nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award will constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition of employment or service or confer any right or benefit under the Award or the Plan unless such right or benefit has specifically accrued under the terms of the Award Agreement and/or Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(g)</b></font><b style="font-weight:bold;">Change in Time Commitment</b>. In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after the date of grant of any Award to the Participant, the Board may determine, to the extent permitted by Applicable Law, to (i) make a corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (ii) in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced or extended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(h)</b></font><b style="font-weight:bold;">Execution of Additional Documents. </b>As a condition to accepting an Award under the Plan, the Participant agrees to execute any additional documents or instruments necessary or desirable, as determined in the Plan Administrator&#8217;s sole discretion, to carry out the purposes or intent of the Award, or facilitate compliance with securities and/or other regulatory requirements, in each case at the Plan Administrator&#8217;s request.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font><b style="font-weight:bold;">Electronic Delivery and Participation</b>. Any reference herein or in an Award Agreement to a &#8220;written&#8221; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access). By accepting any Award, the Participant consents to receive documents by electronic delivery and to participate in the Plan through any on-line electronic system established and maintained by the Plan Administrator or another third party selected by the Plan Administrator. The form of delivery of any Common Stock (e.g., a stock certificate or electronic entry evidencing such shares) shall be determined by the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(j)</b></font><b style="font-weight:bold;">Clawback/Recovery</b>. All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Law and any clawback policy that the Company otherwise adopts, to the extent applicable and permissible under Applicable Law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a Participant&#8217;s right to voluntarily terminate employment upon a &#8220;resignation for good reason,&#8221; or for a &#8220;constructive termination&#8221; or any similar term under any plan of or agreement with the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(k)</b></font><b style="font-weight:bold;">Securities Law Compliance. </b>A Participant will not be issued any shares in respect of an Award unless either (i) the shares are registered under the Securities Act; or (ii) the Company has determined that such issuance would be exempt from the registration requirements of the Securities Act. Each Award also must comply with other Applicable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Law governing the Award, and a Participant will not receive such shares if the Company determines that such receipt would not be in material compliance with Applicable Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(l)</b></font><b style="font-weight:bold;">Transfer or Assignment of Awards; Issued Shares. </b>Except as expressly provided in the Plan or the form of Award Agreement, Awards granted under the Plan may not be transferred or assigned by the Participant. After the vested shares subject to an Award have been issued, or in the case of a Restricted Stock Award and similar awards, after the issued shares have vested, the holder of such shares is free to assign, hypothecate, donate, encumber or otherwise dispose of any interest in such shares provided that any such actions are in compliance with the provisions herein, the terms of the Trading Policy and Applicable Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(m)</b></font><b style="font-weight:bold;">Effect on Other Employee Benefit Plans. </b>The value of any Award granted under the Plan, as determined upon grant, vesting or settlement, shall not be included as compensation, earnings, salaries, or other similar terms used when calculating any Participant&#8217;s benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend, modify, or terminate any of the Company&#8217;s or any Affiliate&#8217;s employee benefit plans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(n)</b></font><b style="font-weight:bold;">Deferrals. </b>To the extent permitted by Applicable Law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may also establish programs and procedures for deferral elections to be made by Participants. Deferrals will be made in accordance with the requirements of Section 409A.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(o)</b></font><b style="font-weight:bold;">Section 409A. </b>Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section 409A, and, to the extent not so exempt, in compliance with the requirements of Section 409A. If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section 409A, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221; under Section 409A is a &#8220;specified employee&#8221; for purposes of Section 409A, no distribution or payment of any amount that is due because of a &#8220;separation from service&#8221; (as defined in Section 409A without regard to alternative definitions thereunder) will be issued or paid before the date that is six months and one day following the date of such Participant&#8217;s &#8220;separation from service&#8221; or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment can be made in a manner that complies with Section 409A, and any amounts so deferred will be paid in a lump sum on the day after such six month period elapses, with the balance paid thereafter on the original schedule.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(p)</b></font><b style="font-weight:bold;">Choice of Law. </b>This Plan and any controversy arising out of or relating to this Plan shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without regard to conflict of law principles that would result in any application of any law other than the law of the State of Delaware.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">10.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">COVENANTS OF THE COMPANY.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></font><b style="font-weight:bold;">Compliance with Law. </b>The Company will seek to obtain from each regulatory commission or agency, as may be deemed necessary, having jurisdiction over the Plan such authority as may be required to grant Awards and to issue and sell shares of Common Stock upon exercise or vesting of the Awards; provided, however, that this undertaking will not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued or issuable pursuant to any such Award. If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary or advisable for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise or vesting of such Awards unless and until such authority is obtained. A Participant is not eligible for the grant of an Award or the subsequent issuance of Common Stock pursuant to the Award if such grant or issuance would be in violation of any Applicable Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">11.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">ADDITIONAL RULES FOR AWARDS SUBJECT TO SECTION 409A.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(a)</b></font><b style="font-weight:bold;">Application. </b>Unless the provisions of this Section of the Plan are expressly superseded by the provisions in the form of Award Agreement, the provisions of this Section shall apply and shall supersede anything to the contrary set forth in the Award Agreement for a Non-Exempt Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(b)</b></font><b style="font-weight:bold;">Non-Exempt Awards Subject to Non-Exempt Severance Arrangements. </b>To the extent a Non-Exempt Award is subject to Section 409A due to application of a Non-Exempt Severance Arrangement, the following provisions of this subsection (b) apply.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.9pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font>If the Non-Exempt Award vests in the ordinary course during the Participant&#8217;s Continuous Service in accordance with the vesting schedule set forth in the Award Agreement, and does not accelerate vesting under the terms of a Non-Exempt Severance Arrangement, in no event will the shares be issued in respect of such Non-Exempt Award any later than the later of: (i) December 31st of the calendar year that includes the applicable vesting date, or (ii) the 60th day that follows the applicable vesting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.75pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font>If vesting of the Non-Exempt Award accelerates under the terms of a Non-Exempt Severance Arrangement in connection with the Participant&#8217;s Separation from Service, and such vesting acceleration provisions were in effect as of the date of grant of the Non-Exempt Award and, therefore, are part of the terms of such Non-Exempt Award as of the date of grant, then the shares will be earlier issued in settlement of such Non-Exempt Award upon the Participant&#8217;s Separation from Service in accordance with the terms of the Non-Exempt Severance Arrangement, but in no event later than the 60th day that follows the date of the Participant&#8217;s Separation from Service. However, if at the time the shares would otherwise be issued the Participant is subject to the distribution limitations contained in Section 409A applicable to &#8220;specified employees,&#8221; as defined in Section 409A(a)(2)(B)(i) of the Code, such shares shall not be issued before the date that is six months following the date of such Participant&#8217;s Separation from Service, or, if earlier, the date of the Participant&#8217;s death that occurs within such six month period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.05pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iii)</b></font>If vesting of a Non-Exempt Award accelerates under the terms of a Non-Exempt Severance Arrangement in connection with a Participant&#8217;s Separation from Service, and such vesting acceleration provisions were not in effect as of the date of grant of the Non-Exempt Award and, therefore, are not a part of the terms of such Non-Exempt Award on the date of grant, then such acceleration of vesting of the Non-Exempt Award shall not accelerate the issuance date of the shares, but the shares shall instead be issued on the same schedule as set forth in the Grant Notice as if they had vested in the ordinary course during the Participant&#8217;s Continuous Service, notwithstanding the vesting acceleration of the Non-Exempt Award. Such issuance schedule is intended to satisfy the requirements of payment on a specified date or pursuant to a fixed schedule, as provided under United States Treasury Regulations Section 1.409A-3(a)(4).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></font><b style="font-weight:bold;">Treatment of Non-Exempt Awards Upon a Transaction for Employees and Consultants. </b>The provisions of this subsection (c) shall apply and shall supersede anything to the contrary set forth in the Plan with respect to the permitted treatment of any Non-Exempt Award in connection with a Transaction if the Participant was either an Employee or Consultant upon the applicable date of grant of the Non-Exempt Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:27.35pt;text-align:justify;text-indent:-27.35pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.25pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font><b style="font-weight:bold;">Vested Non-Exempt Awards. </b>The following provisions shall apply to any Vested Non-Exempt Award in connection with a Transaction:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:59.4pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(1)</b></font>If the Transaction is also a Section 409A Change in Control, then the Acquiring Entity may not assume, continue or substitute the Vested Non-Exempt Award. Upon the Section 409A Change in Control, the settlement of the Vested Non- Exempt Award will automatically be accelerated and the shares will be immediately issued in respect of the Vested Non-Exempt Award. Alternatively, the Company may instead provide that the Participant will receive a cash settlement equal to the Fair Market Value of the shares that would otherwise be issued to the Participant upon the Section 409A Change in Control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:59.4pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(2)</b></font>If the Transaction is not also a Section 409A Change in Control, then the Acquiring Entity must either assume, continue or substitute each Vested Non-Exempt Award. The shares to be issued in respect of the Vested Non-Exempt Award shall be issued to the Participant by the Acquiring Entity on the same schedule that the shares would have been issued to the Participant if the Transaction had not occurred. In the Acquiring Entity&#8217;s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute a cash payment on each applicable issuance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 3.25pt;">date, equal to the Fair Market Value of the shares that would otherwise be issued to the Participant on such issuance dates, with the determination of the Fair Market Value of the shares made on the date of the Transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:27.35pt;text-align:justify;text-indent:-27.35pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.7pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font><b style="font-weight:bold;">Unvested Non-Exempt Awards. </b>The following provisions shall apply to any Unvested Non-Exempt Award unless otherwise determined by the Board pursuant to subsection (e) of this Section.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:59.4pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(1)</b></font>In the event of a Transaction, the Acquiring Entity shall assume, continue or substitute any Unvested Non-Exempt Award. Unless otherwise determined by the Board, any Unvested Non-Exempt Award will remain subject to the same vesting and forfeiture restrictions that were applicable to the Award prior to the Transaction. The shares to be issued in respect of any Unvested Non-Exempt Award shall be issued to the Participant by the Acquiring Entity on the same schedule that the shares would have been issued to the Participant if the Transaction had not occurred. In the Acquiring Entity&#8217;s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute a cash payment on each applicable issuance date, equal to the Fair Market Value of the shares that would otherwise be issued to the Participant on such issuance dates, with the determination of Fair Market Value of the shares made on the date of the Transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:59.4pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(2)</b></font>If the Acquiring Entity will not assume, substitute or continue any Unvested Non-Exempt Award in connection with a Transaction, then such Award shall automatically terminate and be forfeited upon the Transaction with no consideration payable to any Participant in respect of such forfeited Unvested Non-Exempt Award. Notwithstanding the foregoing, to the extent permitted and in compliance with the requirements of Section 409A, the Board may in its discretion determine to elect to accelerate the vesting and settlement of the Unvested Non-Exempt Award upon the Transaction, or instead substitute a cash payment equal to the Fair Market Value of such shares that would otherwise be issued to the Participant, as further provided in subsection (e)(ii) below. In the absence of such discretionary election by the Board, any Unvested Non-Exempt Award shall be forfeited without payment of any consideration to the affected Participants if the Acquiring Entity will not assume, substitute or continue the Unvested Non-Exempt Awards in connection with the Transaction.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:62.65pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.65pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(3)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">The foregoing treatment shall apply with respect to all Unvested Non-Exempt Awards upon any Transaction, and regardless of whether or not such Transaction is also a Section 409A Change in Control.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:14.4pt;margin:0pt 0pt 12pt 3.6pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></font><b style="font-weight:bold;">Treatment of Non-Exempt Awards Upon a Transaction for Non-Employee Directors. </b>The following provisions of this subsection (d) shall apply and shall supersede anything to the contrary that may be set forth in the Plan with respect to the permitted treatment of a Non-Exempt Director Award in connection with a Transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font>If the Transaction is also a Section 409A Change in Control, then the Acquiring Entity may not assume, continue or substitute the Non-Exempt Director Award. Upon the Section 409A Change in Control, the vesting and settlement of any Non- Exempt Director Award will automatically be accelerated and the shares will be immediately issued to the Participant in respect of the Non-Exempt Director Award. Alternatively, the Company may provide that the Participant will instead receive a cash settlement equal to the Fair Market Value of the shares that would otherwise be issued to the Participant upon the Section 409A Change in Control pursuant to the preceding provision.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font>If the Transaction is not also a Section 409A Change in Control, then the Acquiring Entity must either assume, continue or substitute the Non-Exempt Director Award. Unless otherwise determined by the Board, the Non-Exempt Director Award will remain subject to the same vesting and forfeiture restrictions that were applicable to the Award prior to the Transaction. The shares to be issued in respect of the Non-Exempt Director Award shall be issued to the Participant by the Acquiring Entity on the same schedule that the shares would have been issued to the Participant if the Transaction had not occurred. In the Acquiring Entity&#8217;s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute a cash payment on each applicable issuance date, equal to the Fair Market Value of the shares that would otherwise be issued to the Participant on such issuance dates, with the determination of Fair Market Value made on the date of the Transaction.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.45pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(e)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">If the RSU Award is a Non-Exempt Award, then the provisions in this Section 11(e) shall apply and supersede anything to the contrary that may be set forth in the Plan or the Award Agreement with respect to the permitted treatment of such Non-Exempt Award:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font>Any exercise by the Board of discretion to accelerate the vesting of a Non-Exempt Award shall not result</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">in any acceleration of the scheduled issuance dates for the shares in respect of the Non-Exempt Award unless earlier issuance of the shares upon the applicable vesting dates would be in compliance with the requirements of Section 409A.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font>The Company explicitly reserves the right to earlier settle any Non-Exempt Award to the extent permitted and in compliance with the requirements of Section 409A, including pursuant to any of the exemptions available in United States Treasury Regulations Section 1.409A-3(j)(4)(ix).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:26.05pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iii)</b></font>To the extent the terms of any Non-Exempt Award provide that it will be settled upon a Change in Control or Transaction, to the extent it is required for compliance with the requirements of Section 409A, the Change in Control or Transaction event triggering settlement must also constitute a Section 409A Change in Control. To the extent the terms of a Non-Exempt Award provides that it will be settled upon a termination of employment or termination of Continuous Service, to the extent it is required for compliance with the requirements of Section 409A, the termination event triggering settlement must also constitute a Separation From Service. However, if at the time the shares would otherwise be issued to a Participant in connection with a &#8220;separation from service&#8221; such Participant is subject to the distribution limitations contained in Section 409A applicable to &#8220;specified employees,&#8221; as defined in Section 409A(a)(2)(B)(i) of the Code, such shares shall not be issued before the date that is six months following the date of the Participant&#8217;s Separation From Service, or, if earlier, the date of the Participant&#8217;s death that occurs within such six month period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:25.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iv)</b></font>The provisions in this subsection (e) for delivery of the shares in respect of the settlement of a RSU Award that is a Non-Exempt Award are intended to comply with the requirements of Section 409A so that the delivery of the shares to the Participant in respect of such Non-Exempt Award will not trigger the additional tax imposed under Section 409A, and any ambiguities herein will be so interpreted.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">12.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">SEVERABILITY.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">If all or any part of the Plan or any Award Agreement is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any portion of the Plan or such Award Agreement not declared to be unlawful or invalid. Any Section of the Plan or any Award Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:17.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">13.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">TERMINATION OF THE PLAN.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;">The Board may suspend or terminate the Plan at any time. No Incentive Stock Options may be granted after the tenth anniversary of the earlier of: (i) the Adoption Date, or (ii) the date the Plan is approved by the Company&#8217;s stockholders. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:3.25pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">14.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">DEFINITIONS.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;">As used in the Plan, the following definitions apply to the capitalized terms indicated below:</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.65pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(a)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Acquiring Entity</font>&#8221; means the surviving or acquiring corporation (or its parent company) in connection with a Transaction.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.95pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(b)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Adoption Date</font>&#8221; means the date the Plan is first approved by the Board or Compensation Committee.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.3pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(c)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Affiliate</font>&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405 promulgated under the Securities Act. The Board may determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.9pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(d)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Applicable Law</font>&#8221; means the Code and any applicable U.S. or non-U.S. securities, federal, state, material local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (including under the authority of any applicable self-regulating organization such as the Nasdaq Stock Market, New York Stock Exchange,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">or the Financial Industry Regulatory Authority).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.3pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(e)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Appreciation Award</font>&#8221; means (i) a stock option or stock appreciation right granted under the Prior Plan or the Inducement Plan or (ii) an Option or Stock Appreciation Right, in each case with respect to which the exercise or strike price (per share) is at least 100% of the Fair Market Value of the Common Stock subject to the stock option or stock appreciation right, or Option or Stock Appreciation Right, as applicable, on the date of grant.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:20.4pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(f)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Award</font>&#8221; means any right to receive Common Stock, cash or other property granted under the Plan (including an Incentive Stock Option, a Nonstatutory Stock Option, a Restricted Stock Award, a RSU Award, a SAR, a Performance Award or any Other Award).</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(g)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Award Agreement</font>&#8221; means a written agreement between the Company and a Participant evidencing the terms and conditions of an Award. The Award Agreement generally consists of the Grant Notice and the agreement containing the written summary of the general terms and conditions applicable to the Award and which is provided to a Participant along with the Grant Notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.9pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(h)</b></font> &#8220;<font style="font-style:italic;font-weight:bold;">Board</font>&#8221; means the board of directors of the Company (or its designee). Any decision or determination made by the Board shall be a decision or determination that is made in the sole discretion of the Board (or its designee), and such decision or determination shall be final and binding on all Participants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.45pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Capitalization Adjustment</font>&#8221; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.75pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(j)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Cause</font>&#8221; has the meaning ascribed to such term in any written agreement between the Participant and the Company or an Affiliate defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events: (i) such Participant&#8217;s actual or attempted commission of, or participation in, a fraud or act of dishonesty against the Company or an Affiliate; (ii) such Participant&#8217;s intentional, material violation of any contract or agreement between the Participant and the Company or an Affiliate or of any statutory duty owed to the Company or an Affiliate; (iii) such Participant&#8217;s unauthorized use or disclosure of the Company&#8217;s or any of its Affiliate&#8217;s confidential information or trade secrets; or (iv) such Participant&#8217;s gross misconduct. The determination that a termination of the Participant&#8217;s Continuous Service is either for Cause or without Cause will be made by the Board with respect to Participants who are executive officers of the Company and by the Company&#8217;s Chief Executive Officer with respect to Participants who are not executive officers of the Company. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant will have no effect upon any determination of the rights or obligations of the Company or an Affiliate or such Participant for any other purpose.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.9pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(k)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Change in Control</font>&#8221; or &#8220;<font style="font-style:italic;font-weight:bold;">Change of Control</font>&#8221; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events; provided, however, to the extent necessary to avoid adverse personal income tax consequences to the Participant in connection with an Award, such event or events, as the case may be, also constitute a Section 409A Change in Control:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:39.6pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18.35pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font>any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control shall not be deemed to occur (A) on account of the acquisition of securities of the Company directly from the Company, (B) on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C) solely because the level of Ownership held by any Exchange Act Person (the &#8220;<font style="font-style:italic;font-weight:bold;">Subject Person</font>&#8221;) exceeds the</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 3.25pt;">designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control shall be deemed to occur;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:39.6pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18.75pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ii)</b></font>there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A) outstanding voting securities representing more than 50% of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than 50% of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:39.6pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iii)</b></font>there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:39.6pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iv)</b></font>individuals who, on the date the Plan is adopted by the Board, are members of the Board (the &#8220;<font style="font-style:italic;font-weight:bold;">Incumbent Board</font>&#8221;) cease for any reason to constitute at least a majority of the members of the Board; provided, however, that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member shall, for purposes of this Plan, be considered as a member of the Incumbent Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;">Notwithstanding the foregoing or any other provision of this Plan, (A) the term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company, and (B) the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant shall supersede the foregoing definition with respect to Awards subject to such agreement; provided, however, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition shall apply.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.5pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(l)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Code</font>&#8221; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:20.35pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(m)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Committee</font>&#8221; means the Compensation Committee and any other committee of one or more Directors to whom authority has been delegated by the Board or Compensation Committee in accordance with the Plan.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.95pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(n)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Common Stock</font>&#8221; means the common stock of the Company.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.65pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(o)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Company</font>&#8221; means MaxCyte, Inc., a Delaware corporation, and any successor thereto.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.95pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(p)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Compensation Committee</font>&#8221; means the Compensation Committee of the Board.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.9pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(q)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Consultant</font>&#8221; means any person, including an advisor, who is (i) engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii) serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#8220;Consultant&#8221; for purposes of the Plan. Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form S-8 Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#8217;s securities to such person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.3pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(r)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Continuous Service</font>&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Director or Consultant or a change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s Continuous Service; provided, however, that if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of Continuous Service. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#8217;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law. In addition, to the extent required for exemption from or compliance with Section 409A, the determination of whether there has been a termination of Continuous Service will be made, and such term will be construed, in a manner that is consistent with the definition of &#8220;separation from service&#8221; as defined under United States Treasury Regulation Section 1.409A-1(h) (without regard to any alternative definition thereunder).</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.05pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(s)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Corporate Transaction</font>&#8221; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events:</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:42.85pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18.4pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(i)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">a sale or other disposition of all or substantially all, as determined by the Board, of the consolidated assets of the Company and its Subsidiaries;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:42.85pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18.85pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(ii)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">a sale or other disposition of at least 50% of the outstanding securities of the Company;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:42.85pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(iii)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:39.6pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20.05pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iv)</b></font>a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.85pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(t)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Director</font>&#8221; means a member of the Board.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.95pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(u)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">determine</font>&#8221; or &#8220;<font style="font-style:italic;font-weight:bold;">determined</font>&#8221; means as determined by the Board or the Committee (or its designee) in its sole discretion.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(v)</b></font> &#8220;<font style="font-style:italic;font-weight:bold;">Disability</font>&#8221; means, with respect to a Participant, such Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Section 22(e)(3) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:20.85pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(w)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Effective Date</font>&#8221; means the date on which the Plan is approved by the Company&#8217;s stockholders.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.65pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(x)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Employee</font>&#8221; means any person employed by the Company or an Affiliate. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.65pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(y)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Employer</font>&#8221; means the Company or the Affiliate that employs the Participant.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:23.05pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.35pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(z)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8220;<font style="font-style:italic;font-weight:bold;">Entity</font>&#8221; means a corporation, partnership, limited liability company or other entity.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(aa)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Exchange Act</font>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(bb) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Exchange Act Person</font>&#8221; means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i) the Company or any Subsidiary of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv) an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v) any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(cc)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Fair Market Value</font>&#8221; means, as of any date, unless otherwise determined by the Board, the value of the Common Stock (as determined on a per share or aggregate basis, as applicable) determined as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:39.6pt;margin:0pt 0pt 12pt 3.25pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18.4pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(i)</b></font>If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value will be the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:42.85pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18.85pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(ii)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">If there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:42.85pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:19.3pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">(iii)</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">In the absence of such markets for the Common Stock, or if otherwise determined by the Board, the Fair Market Value will be determined by the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20.8pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(dd)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Full Value Award</font>&#8221; means (i) a stock award granted under the Prior Plan or the Inducement Plan or (ii) an Award, in each case that is not an Appreciation Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(ee) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Governmental Body</font>&#8221; means any: (i) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (ii) U.S. federal, state, local, municipal, non-U.S. or other government; (iii) governmental or regulatory body, or quasi-governmental body of any nature (including any governmental division, department, administrative agency or bureau, commission, authority, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the avoidance of doubt, any Tax authority) or other body exercising similar powers or authority; or (iv) self-regulatory organization (including the Nasdaq Stock Market, New York Stock Exchange, and the Financial Industry Regulatory Authority).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(ff) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Grant Notice</font>&#8221; means the notice provided to a Participant that he or she has been granted an Award under the Plan and which includes the name of the Participant, the type of Award, the date of grant of the Award, number of shares of Common Stock subject to the Award or potential cash payment right, (if any), the vesting schedule for the Award (if any) and other key terms applicable to the Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(gg)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Incentive Stock Option</font>&#8221; means an option granted pursuant to Section 4 of the Plan that is intended to be, and qualifies as, an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-indent:0pt;width:20.8pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(hh)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Inducement Plan</font>&#8221; means the MaxCyte, Inc. 2021 Inducement Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(ii)&#160;&#160;&#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Materially Impair</font>&#8221; means any amendment to the terms of the Award that materially adversely affects the Participant&#8217;s rights under the Award. A Participant&#39;s rights under an Award will not be deemed to have been Materially Impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant&#8217;s rights. For example, the following types of amendments to the terms of an Award do not Materially Impair the Participant&#8217;s rights under the Award: (i) imposition of reasonable restrictions on the minimum number of shares subject to an Option that may be exercised, (ii) to maintain the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code; (iii) to change the terms of an Incentive Stock</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 3.25pt;">Option in a manner that disqualifies, impairs or otherwise affects the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code; (iv) to clarify the manner of exemption from, or to bring the Award into compliance with or qualify it for an exemption from, Section 409A; or (v) to comply with other Applicable Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(jj)&#160;&#160;&#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Non-Employee Director</font>&#8221; means a Director who either (i) is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act (&#8220;<font style="font-style:italic;font-weight:bold;">Regulation S-K</font>&#8221;)), does not possess an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item 404(b) of Regulation S-K; or (ii) is otherwise considered a &#8220;non-employee director&#8221; for purposes of Rule 16b-3.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;">(kk) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Non-Exempt Award</font>&#8221; means any Award that is subject to, and not exempt from, Section 409A, including as the result of (i) a deferral of the issuance of the shares subject to the Award which is elected by the Participant or imposed by the Company or (ii) the terms of any Non-Exempt Severance Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.95pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ll)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Non-Exempt Director Award</font>&#8221; means a Non-Exempt Award granted to a Participant who was a Director but not an Employee on the applicable grant date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(mm) </b>&#8220;<font style="font-style:italic;font-weight:bold;">Non-Exempt Severance Arrangement</font>&#8221; means a severance arrangement or other agreement between the Participant and the Company that provides for acceleration of vesting of an Award and issuance of the shares in respect of such Award upon the Participant&#8217;s termination of employment or separation from service (as such term is defined in Section 409A(a)(2)(A)(i) of the Code (and without regard to any alternative definition thereunder) (&#8220;<font style="font-style:italic;font-weight:bold;">Separation from Service</font>&#8221;)) and such severance benefit does not satisfy the requirements for an exemption from application of Section 409A provided under United States Treasury Regulations Section 1.409A-1(b)(4), 1.409A-1(b)(9) or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-indent:0pt;width:20.8pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(nn)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Nonstatutory Stock Option</font>&#8221; means any option granted pursuant to Section 4 of the Plan that does not qualify as an Incentive Stock Option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:21.3pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(oo)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Officer</font>&#8221; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20.8pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(pp)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Option</font>&#8221; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(qq)&#160;&#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Option Agreement</font>&#8221; means a written agreement between the Company and the Optionholder evidencing the terms and conditions of the Option grant. The Option Agreement includes the Grant Notice for the Option and the agreement containing the written summary of the general terms and conditions applicable to the Option and which is provided to a Participant along with the Grant Notice. Each Option Agreement will be subject to the terms and conditions of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.6pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(rr)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Optionholder</font>&#8221; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(ss) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Other Award</font>&#8221; means an award valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the Fair Market Value at the time of grant), that is not an Incentive Stock Option, Nonstatutory Stock Option, SAR, Restricted Stock Award, RSU Award or Performance Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20.55pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(tt)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Other Award Agreement</font>&#8221; means a written agreement between the Company and a holder of an Other Award evidencing the terms and conditions of an Other Award grant. Each Other Award Agreement will be subject to the terms and conditions of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(uu) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Own,</font>&#8221; &#8220;<font style="font-style:italic;font-weight:bold;">Owned,</font>&#8221; &#8220;<font style="font-style:italic;font-weight:bold;">Owner,</font>&#8221; &#8220;<font style="font-style:italic;font-weight:bold;">Ownership</font>&#8221; means that a person or Entity will be deemed to &#8220;Own,&#8221; to have</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">&#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:21.3pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(vv)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Participant</font>&#8221; means an Employee, Director or Consultant to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(ww) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Performance Award</font>&#8221; means an Award that may vest or may be exercised or a cash award that may vest or become earned and paid contingent upon the attainment during a Performance Period of certain Performance Goals and which is granted under the terms and conditions of Section 5(b) pursuant to such terms as are approved by the Board. In addition, to the extent permitted by Applicable Law and set forth in the applicable Award Agreement, the Board may determine that cash or other property may be used in payment of Performance Awards. Performance Awards that are settled in cash or other property are not required to be valued in whole or in part by reference to, or otherwise based on, the Common Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(xx) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Performance Criteria</font>&#8221; means the one or more criteria that the Board will select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish such Performance Goals may be based on any one of, or combination of, the following as determined by the Board: earnings (including earnings per share and net earnings); earnings before interest, taxes and depreciation; earnings before interest, taxes, depreciation and amortization; net income/loss adjusted for interest expense, interest income, other income/expenses, net provision for/benefit from income taxes, depreciation and amortization, legal settlement expenses and stock-based compensation expenses; other earnings measures; total stockholder return; return on equity or average stockholder&#8217;s equity; return on assets, investment, or capital employed; stock price; margin (including gross margin); income (before or after taxes); operating income; operating income after taxes; pre-tax profit; operating cash flow; sales or revenue targets; increases in revenue or product revenue; expenses and cost reduction goals; improvement in or attainment of working capital levels; economic value added (or an equivalent metric); market share; cash flow; cash flow per share; share price performance; debt reduction; customer satisfaction; stockholders&#8217; equity; capital expenditures; debt levels; operating profit or net operating profit; workforce diversity; growth of net income or operating income; pre-clinical development related compound goals; operations within or below pre-determined annual budget, sales of certain number of instruments, reagents and/or service contracts; financing; regulatory milestones, including approval of a compound; stockholder liquidity; corporate governance and compliance; product commercialization; intellectual property; personnel matters; progress of internal research or clinical programs; progress of partnered programs; partner satisfaction; budget management; clinical achievements; completing phases of a clinical study (including the treatment phase); announcing or presenting preliminary or final data from clinical studies; in each case, whether on particular timelines or generally; timely completion of clinical trials; submission of INDs and NDAs and other regulatory achievements; partner or collaborator achievements; internal controls, including those related to the Sarbanes-Oxley Act of 2002; research progress, including the development of programs; investor relations, analysts and communication; manufacturing achievements (including obtaining particular yields from manufacturing runs and other measurable objectives related to process development activities); strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property; establishing relationships with commercial entities with respect to the marketing, distribution and sale of the Company&#8217;s products (including with group purchasing organizations, distributors and other vendors); supply chain achievements (including establishing relationships with key manufacturers or suppliers of active pharmaceutical ingredients and other component materials and manufacturers of the Company&#8217;s products); co-development, co-marketing, profit sharing, joint venture or other similar arrangements; individual performance goals; corporate development and planning goals; and other measures of performance selected by the Board or Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(yy) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Performance Goals</font>&#8221; means, for a Performance Period, the one or more goals established by the Board for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Board (i) in the Award Agreement at the time the Award is granted or (ii) in such other document setting forth the Performance Goals at the time the Performance Goals are established, the Board will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (1) to exclude restructuring and/or other nonrecurring charges; (2) to exclude exchange rate effects; (3) to exclude the effects of changes to generally accepted accounting principles; (4) to exclude the effects of any statutory adjustments to corporate tax rates; (5) to exclude the effects of items that are &#8220;unusual&#8221; in nature or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">occur &#8220;infrequently&#8221; as determined under generally accepted accounting principles; (6) to exclude the dilutive effects of acquisitions or joint ventures; (7) to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture; (8) to exclude the effect of any change in the outstanding shares of Common Stock by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9) to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans; (10) to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; and (11) to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles. In addition, the Board retains the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for such Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Award Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(zz) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Performance Period</font>&#8221; means the period of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to vesting or exercise of an Award. Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;">(aaa) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Plan</font>&#8221; means this MaxCyte, Inc. 2022 Equity Incentive Plan, as amended from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;">(bbb) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Plan Administrator</font>&#8221; means the person, persons, and/or third-party administrator designated by the Company to administer the day to day operations of the Plan and the Company&#8217;s other equity incentive programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;white-space:pre-wrap;">(ccc)  </b>&#8220;<font style="font-style:italic;font-weight:bold;">Post-Termination Exercise Period</font>&#8221; means the period following termination of a Participant&#8217;s Continuous Service within which an Option or SAR is exercisable, as specified in Section 4(h).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;white-space:pre-wrap;">(ddd)  </b>&#8220;<font style="font-style:italic;font-weight:bold;">Prior Plan</font>&#8221; means the Company&#8217;s Long-Term Incentive Plan, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;white-space:pre-wrap;">(eee)  </b>&#8220;<font style="font-style:italic;font-weight:bold;">Prior Plan&#8217;s Available Reserve</font>&#8221; means the number of shares available for the grant of new awards under the Prior Plan as of immediately prior to the Effective Date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(fff) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Prior Plans&#8217; Returning Shares</font>&#8221; means shares subject to outstanding stock awards granted under the Prior Plan or the Inducement Plan and that following the Effective Date: (A) are not issued because such stock award or any portion thereof expires or otherwise terminates without all of the shares covered by such stock award having been issued; (B) are not issued because such stock award or any portion thereof is settled in cash; or (C) are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition required for the vesting of such shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;white-space:pre-wrap;">(ggg)  </b>&#8220;<font style="font-style:italic;font-weight:bold;">Restricted Stock Award</font>&#8221; or &#8220;<font style="font-style:italic;font-weight:bold;">RSA</font>&#8221; means an Award of shares of Common Stock which is granted pursuant to the terms and conditions of Section 5(a).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(hhh) </b>&#8220;<font style="font-style:italic;font-weight:bold;">Restricted Stock Award Agreement</font>&#8221; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. The Restricted Stock Award Agreement includes the Grant Notice for the Restricted Stock Award and the agreement containing the written summary of the general terms and conditions applicable to the Restricted Stock Award and which is provided to a Participant along with the Grant Notice. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:19.3pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(iii)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">RSU Award</font>&#8221; or &#8220;<font style="font-style:italic;font-weight:bold;">RSU</font>&#8221; means an Award of restricted stock units representing the right to receive an issuance of shares of Common Stock which is granted pursuant to the terms and conditions of Section 5(a).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(jjj) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">RSU Award Agreement</font>&#8221; means a written agreement between the Company and a holder of a RSU Award evidencing the terms and conditions of a RSU Award. The RSU Award Agreement includes the Grant Notice for the RSU Award and the agreement containing the written summary of the general terms and conditions applicable to the RSU Award and which is provided to a Participant along with the Grant Notice. Each RSU Award Agreement will be subject to the terms and conditions of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 7.5pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;">(kkk) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Rule 16b-3</font>&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-indent:0pt;width:19.3pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(lll)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Rule 405</font>&#8221; means Rule 405 promulgated under the Securities Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;">(mmm) </b>&#8220;<font style="font-style:italic;font-weight:bold;">Section 409A</font>&#8221; means Section 409A of the Code and the regulations and other guidance thereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(nnn) </b>&#8220;<font style="font-style:italic;font-weight:bold;">Section 409A Change in Control</font>&#8221; means a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the Company&#8217;s assets, as provided in Section 409A(a)(2)(A)(v) of the Code and United States Treasury Regulations Section 1.409A-3(i)(5) (without regard to any alternative definition thereunder).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;white-space:pre-wrap;">(ooo)  </b>&#8220;<font style="font-style:italic;font-weight:bold;">Securities Act</font>&#8221; means the Securities Act of 1933, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;">(ppp) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Share Reserve</font>&#8221; means the number of shares available for issuance under the Plan as set forth in Section 2(a).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;white-space:pre-wrap;">(qqq)  </b>&#8220;<font style="font-style:italic;font-weight:bold;">Stock Appreciation Right</font>&#8221; or &#8220;<font style="font-style:italic;font-weight:bold;">SAR</font>&#8221; means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section 4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(rrr) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">SAR Agreement</font>&#8221; means a written agreement between the Company and a holder of a SAR evidencing the terms and conditions of a SAR grant. The SAR Agreement includes the Grant Notice for the SAR and the agreement containing the written summary of the general terms and conditions applicable to the SAR and which is provided to a Participant along with the Grant Notice. Each SAR Agreement will be subject to the terms and conditions of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(sss) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Subsidiary</font>&#8221; means, with respect to the Company, (i) any corporation of which more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">(ttt)</b></font>&#8220;<font style="font-style:italic;font-weight:bold;">Ten Percent Stockholder</font>&#8221; means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:19.8pt;margin:0pt 0pt 12pt 3.25pt;"><b style="font-weight:bold;">(uuu) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Trading Policy</font>&#8221; means the Company&#8217;s policy permitting certain individuals to sell Company shares only during certain &#8220;window&#8221; periods and/or otherwise restricts the ability of certain individuals to transfer or encumber Company shares, as in effect from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;white-space:pre-wrap;">(vvv)  </b>&#8220;<font style="font-style:italic;font-weight:bold;">Transaction</font>&#8221; means a Corporate Transaction or a Change in Control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;">(www) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Unvested Non-Exempt Award</font>&#8221; means the portion of any Non-Exempt Award that had not vested in accordance with its terms upon or prior to the date of any Transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 23.05pt;"><b style="font-weight:bold;">(xxx) &#160;</b>&#8220;<font style="font-style:italic;font-weight:bold;">Vested Non-Exempt Award</font>&#8221; means the portion of any Non-Exempt Award that had vested in accordance with its terms upon or prior to the date of a Transaction.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mxct-20240611.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/12/2024 3:21:57 AM-->
<!--Modified on: 6/12/2024 3:21:57 AM-->
<xsd:schema targetNamespace="http://www.maxcyte.com/20240611" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-roles="http://fasb.org/srt-roles/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:attributeFormDefault="unqualified" xmlns:srt="http://fasb.org/srt/2023" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:mxct="http://www.maxcyte.com/20240611" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="mxct-20240611_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mxct-20240611_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>mxct-20240611_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/12/2024 3:21:57 AM-->
<!--Modified on: 6/12/2024 3:21:57 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address State Or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Adress Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Ex Transition Period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>mxct-20240611_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/12/2024 3:21:57 AM-->
<!--Modified on: 6/12/2024 3:21:57 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="mxct-20240611.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638537593176367416" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638537593176367416" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638537593176367416" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638537593176367416" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638537593176367416" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638537593176367416" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638537593176367416" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638537593176367416" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638537593176367416" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638537593176367416" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638537593176367416" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638537593176367416" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638537593176367416" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638537593176367416" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638537593176367416" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638537593176367416" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638537593176367416" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine2_638537593176367416" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638537593176377427" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638537593176377427" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638537593176377427" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638537593176377427" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638537593176377427" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638537593176377427" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638537593176377427" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638537593176377427" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638537593176377427" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638537593176377427" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638537593176377427" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638537593176377427" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638537593176377427" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638537593176377427" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638537593176377427" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638537593176377427" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod_638537593176386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityExTransitionPeriod_638537593176386771" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638537593176386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638537593176386771" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638537593176386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638537593176386771" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638537593176386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_638537593176386771" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638537593176386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_638537593176386771" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638537593176386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638537593176386771" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638537593176397421" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638537593176397421" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm139694547046272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 11, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 11,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MaxCyte, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2210438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9713 Key West Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Adress Line Two</a></td>
<td class="text">Suite 400 <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rockville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">944-1700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MXCT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001287098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( *J%S%C]0C/B[P   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( *J%S%B97)PC$ 8  )PG   3
M      "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ JH7,
M6 8%.^MZ!   [!$  !@              ("!#@@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( *J%S%B?H!OPL0(  .(,   -
M      "  ;X,  !X;"]S='EL97,N>&UL4$L! A0#%     @ JH7,6)>*NQS
M    $P(   L              ( !F@\  %]R96QS+RYR96QS4$L! A0#%
M  @ JH7,6!PX9>H_ 0  / (   \              ( !@Q   'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( *J%S%@D'INBK0   /@!   :
M  "  >\1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M *J%S%AED'F2&0$  ,\#   3              "  =02  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     )  D /@(  !X4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mxct-20240611x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>mxct-20240611.xsd</File>
    <File>mxct-20240611_lab.xml</File>
    <File>mxct-20240611_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="mxct-20240611x8k.htm">mxct-20240611x8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mxct-20240611x8k.htm": {
   "nsprefix": "mxct",
   "nsuri": "http://www.maxcyte.com/20240611",
   "dts": {
    "schema": {
     "local": [
      "mxct-20240611.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "mxct-20240611_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mxct-20240611_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "mxct-20240611x8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mxct-20240611x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mxct-20240611x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Adress Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.maxcyte.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001558370-24-009097-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-24-009097-xbrl.zip
M4$L#!!0    ( *J%S%BQ=+%Y= ,  $T,   1    ;7AC="TR,#(T,#8Q,2YX
M<V2U5EUOTS 4?4?B/YB\)TY25K1J']H82),VD,:0]H9<QVTM$CO8#NW^/==N
MG-9MTG4(GI;YG'ONIZ][=KFJ2O2;*<VE.(^R)(T0$U067,S/HT;'1%/.H\N+
MMV_.WL7QT_7#'2HD;2HF#***$<,*M.1F@1YE71.![IE2O"S1M>+%G"&4I<DX
MR9,3%,>MQC718",%<F)YDG7(QU9/B@D:XRS'>9J_1Z-)GDU./J"K^XYX#_'-
M^(O,E2XFFBY819 A:L[,%U(Q71/*SJ.%,?4$X^5RF51D19\-2ZBLG$XZSK((
M$6,4GS:&?9:JNF$STI0&*B)^-:1TSJ%0);-U" A;,%16Z D$$7A;CA*IYN H
MS?#3_=TW%Y\G%ZQ6C-HB!#:KJ2J]U2E6LF1XP_2VT"R+Z,YR1O3467G$9C?R
M=-HH!9U^[NC.B68TF<O?V*.!B6*SP;#&&- N9P *$RJWO!.\!CMJ.2@YPD]W
M7/S<RL\\UP/Y.20(5BLS5(\."@P:HPX4'="M0.:$U+UQ6"!0+2&# QE:> H7
MHHN:T_Z& !"F9VHUP 1DKQ(#E>N@P(")ILK[NI>GF*T,$YI/2Q9;&E/$P.;0
M<6XW1SM9LA%&#0W6&@S\"69>&G>@=&S"J>X7=U @73#>3P4@(*[V&M5>U.ST
M]!0[M-,T:J>>0=  8PM;^3Q.1_$HVR0Z/^9NM[2N'2NZZ$_"(D$61RRM;B9Z
MIR&LB>8OKZZ8"VV(H&S[\O,#([_+KU;4'+&/N]H?J%ZQN:1T:U>% \AF89)V
M'?'>735>[RH>P6."D'M.B!#2N)%W9_ZTKKF8R?8(#NVX3&PO'V$0D/WX_G [
MF*1K^DW[JOJ_5Z+X) PWS[>@K"KG,T(<AN<H9A>+CZ9@,RZXBSR%6J4H1EY@
M^Y.( JW5T);<&=[5V)5OX%'_*B[<-[Q,&K2<I=W@K75+.61)24F;\B\,-Y$-
MV[6GOBT[W?*;^('-D+ON$WN)SR/-J[JTP^K.%NX-M",;^]'\ >DF,$N>8O4/
MC+]K]FZ%6L=>@BBZI[*WCD!$UDP9#MM[\XS@?Y962::O30M,6/E_\CG#NQ>M
M/0DOI+N.D)I4!HG>7WM#RVC]0_%.4B=VP,3^URV]V![%60Y+/@'7/M[#8?3_
M'CHR &]@/9^\TN?^X]?G5 _1[8>=C]'&[;H):Y6+/U!+ P04    " "JA<Q8
MP!4C[:L%   400  %0   &UX8W0M,C R-# V,3%?;&%B+GAM;-6<X6_B-AC&
MOT_:__ >^[))%]*DZTU%;4^4ZTW5Z+6Z,NVT:3J%Q("UQ$:.*?2_/SN) PDV
M4.AEYLLUY7WR^'G='PYNTKMXOTAB>$(LQ91<MKSV20L0"6F$R?BR-4N=( TQ
M;KV_^O&'BS>.\^7Z<Q\B&LX21#B$# 4<13#'? (#.IT&!.X08SB.X9KA:(P
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M$>J7K6&V.F6[GNV[K92'5DY1-3<81,-5*WX#OY?+%G\4/]? [?5Z3M9J2?4
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M*[H$6+XCSF"V/_]4)YG5IS\\A@ I@8";QO"GW);%8M4Z( =GTOG5H%8OST%
M8V"!X5$$ ;WN0L3ZL%>!/\^\ICMT$K@[RQ\%ES?RZ8_NU>W)?M$O%ZJ!- ]W
M=5?OWEFVO4$<\^PY<H04YG^<>>?0TF+[ 2:8Z7/-[\;I+UV\N.TU3B_-@7+X
M/9B_PN6-;>P8ST;,FB7IW 4$V;^L_GU$@ TZT+RK[TV17';/R-6Q[@Z+5Q=W
M\W2))!1RPBM*T7325M)N##L@YAS<T4FI[Q$6<*/HWHT009W,O@>DM_K81F1$
M] $-N\%ML'K$SR!X9 ^H*4:_K3Z0Q" ?7R=%=^/LWE,LL;MR=J;:K.P1/,7
M<L-I7^9_7NI5JUQM[E4:/P\/A_/TF2R(SQ;8CZN7V&,77,GSCNNDXB)LF,W"
MM5'/E]7F!6X<WA2_[?WXP;7FVGQ%X<2\L$&BNGN?7T#96,Q_\E% ;-*G@T8.
M&W52!#$0/);!K? ]1N?3;'F]V7V[!V!]8?8>9E-XS!C#)0Y5+!#01&$.'TR4
MJ)5%-O;CC+,WE5.Q H:K=(C>14&'(-P'?P5L$0V(:.X(:<1VAQ1W]"'%,"IP
M1\@$*$$2+!_$(B". 3@-7$!K;V 'V"'NP+?'R ?-XYMC]F;T@JL!7G <5Z$/
M$CDO ^@'Z.6,XV>F:\/'Z7O4A[+H7-XO_>TRE]X!I?!2+N8IRZ$3X1(7WUSW
MBH_FNK:&@20!,$;21%QY5@!<0",N R>:IOL).W%T/2Y6I*JO7W _*KYE#,;Z
MS7EY%LICI#5(VR7HHH8:XQ[HDP\,X<6\HMPC/&TYPK!R! B,/@D)ZB?RD.L#
M&R9<4B[BMB"=YDNS>W?%/*H<U)$D"SPT7*9J>(.T;;BVI0-RG/8)J 30"W:"
ML*=JKVB8=<VXX Y:XU/--H^ZW?8*"'L/!>I%8#RDJJA@3I02A$TE;4_(J@A\
MV/*=4_;<(U1BZ=Y7MK6#JG'OS#13+M[)];A>KW6OL7!U-1A^/VUW>F9Q%:(+
MT'!Z IRY,BPJ!B?M:A\7HW?8=DOQ),5KOC\@WFRZ7Q]5CO=^_2J?7*B7PZOK
M_EZ_>.YM!MUEPBF[^F)TC]IN MTWQ+U( 96P?*$?1CSPY/H/M^V$M!*9O$7.
M&>!Z@WVQ*.\X)Q<D4\6XI:BY8DO!>;.EB2;\D$6#2+A #/-!CC"YO>5J9BLO
M"E?'U^?: :Z?C,MQ1DJJI=UM7C;W+O>[U;/CVW,O[Q[>:*URE!F0:ED[;9_D
M;L_W_.ZXO6]?JOF#7WD_7I/]Z_*.4XD+LK3-#EQW3J;(%XM;K*\;ZUM.WW+Z
M^\#ZEM/7FX#\ /FOF@>WR*; IR+#35J3*]S\JW>0;F/?7S ?<(;HOWI&9&&=
M"9%_&2-XF,+#QOY4.Y8%-+=5.._<]3]NF>D],M-IM(F6*142100H)L+TS2??
M=1TT[%CPWOTL.(W#EZOH#<VR6^F2<116&(N2QG3]_6:/7'??,<\JP<41,;Y5
MB^W<>)2/M_0^12 :M@(B-0)7[V;0_PN\("*01G2'[4<RQIZ3%SG/B5R+&Y$<
M\%+R/K<<><^1D:4)3<2$'0O-P7=!LO*G%P3_Q/O:-^^H;0RC?>-/)EA=5YI;
MKMMRW4+A>&J+'N;_Q3HRCEW?5[:@6X[T\>^F<"(8 O?KH%*];!Y>%H;MJ$S!
MDQY5AZ!3[!OX-M25Z 1[71*@X^/* GLZWD$:=0JHFF/0=0:"M#'2608$/.Z"
M*T#8-I"I] 3+1S $ IAKTW7(MN<.@PY=KNC3E 7L(X.8EA.6ZPA7F85<'"R?
M6F(."TC):)?Z:_E/;*4Y;FRQ0A]]6NB#9K'0GN+HN\9)X9\/>YU5GRIL&W^#
M+H=,]9#X%+^YH?P5 %5]A(@S7.E77*X+<V5C6+\Q4"LAI(F5NI^NX%X8O]0C
M87QS_/-'71[OG3=>M%*G/K92]ZYXHV8^(>8T#7"FSK >9#-U0",0F^BT4K_C
MLL6T@4]8*^"@*&>*SBI9! N%M90I<[!OV6/Z<7IT $N(<F L\,0C@!=X#_0,
M=G2:!(%UG6ZJ1K1FNH$]PP]3I8S9RWA(E'?Q9 4OJ3-XM &</FI.\!$674M6
M6VO9^:N"@]O"D:,?7W+$$\^.EKL@O;G5CC>D%O6L8M.+NW?+B)VNCSKR"X!*
MG13P/ B3M$F#R)*516%>-4CA10'H?RU4."]12ST"46*\TB9<&+?')O@0)6P/
M\=B/7/]\D9<G]?,F?""'@Z$5W%'B;SJLC:P,OS/))-"-?)%@@;2(H:DM11'U
M5E$6S9:<-TQ95"3PM\1H+7\%>2:*RD_B8W&:271OFE.DQ>H&UP+20SE>D'BT
M3_K8"P8>"Y_M6Q[8"M?SJ;VIP-P.@SM[QO:A>/XG5+7)9%OTI.DG5.[W7<L)
M6 (//'GX'O5;B.-C:#Y&9<^C=H>V]F<UYU>1.!ZA37P08BT'S!JR0W2PXPS
MJL)DC>4: FP^G49U &?$8["FJ@>B7?HF%3$)7,6'@DG_+ED!3#_UF75\0Z<B
MDDW6C?CI(^H0FQ[N@U*U0O_P4^5P8"?AP*:^F&$(B*"9;(%(C9REA=^!5P'?
MG9SN\8<PG=O)SJ:Q %X+[3V-;\"$A*JW U!Q] ;=%WQ'$.TH0V=@N!?Z57\&
M%_L([7,*)![1Z74::KHM!%2@#_P(#J&4D04A RJ3@0[:Q>H->M$.$L9,'>P1
MQD9Z&-!D.*8%13NN!^S*LN@U E--?P 7]QEN$Y!X=##PV.S4<B:G]U"W$WP_
MRK'!0PB'..$4@I3-HC6;NEH,F=!T-$9LYR)[W;3LZ!"KZ3DG>)SW/F1BN_V?
M8;]1K4RS O19[GN6C21U*<)PSH;8B(<X3>:U:9Z7[/5?!UQ-MO<"F,JE+&40
M7_>L?G+3QA2'&2Y\G,YQ8,K!RCN'7,SF,02F2I11+!_=@@9*%32EXNL1$&40
MG<DY/+'@3]YFQ^_,_/!,@:3S+HT0!]T7[&!?C+J=2!*ZL_!$FS'%9J Z87QO
M+*QU_E0KS_KV8^HG$ZU1T3A4$&"8?!I@*@!_+E5]U5$'V(<Y5&*,\!0&:%/
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M*=&)R[6=NOR"+OO]P2%@2]5UYT&OZQBJ@LH7Q=<G[>*#WT]41_RCF4::J3?
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M:3+R$D4G4[&7]#VJ)65A9F3USK6,V8'52>0TJ[G&&'YU@I[]]7]02P,$%
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M:$"TZ3GPWULTPKYN4_B[(M@/6N+'P?P-S/9 H,47$1L_J%*,/23@I(%('H_
M!$KYQG1U&ILI[SRF1^KAML<@D>DTDPU&%E-/8,;%5WX:10?[!\_,NWS!,Z.?
M6WB3OY-3N.J!]T<>C$#<MB@8+WNE,*R/^V&HD3)9=//PRSW8R(D$I578&%^*
M7GVD(UJ] K5&<KYV@/KQ'=G:>7;;\NPFFWMV]E3N=_VC7[-YUK"+][9LT%!P
MH=IBV5SB/^3PP>![A;:!)WHQ&Q.>X'T;N\*$V+[6OL"[8M!NBLD;N'8@*())
MB*<_C _%R.!G;5.& ^E\Z72<%LVKK,XF69XURU>760+"!S_ O?GDZ9%GTA*\
M@O_WLC(73^+IIXNJ!)WU:%KF9?7JWY[0_SM2, G_BTL6'[3*:2O(WT\"L_VI
MLN058D,^T8"-$ JRB"]@@X&N_/0HGC5I]2K.K^-E+;OIY<O]PV?_<<2.G: W
MG@00C^\".+)S0+?G@$[_# XHJ)6T(AUW'US1+1V.A\_W#V__>,PV/A[I]$,S
M*<]22N9XY\@IGQWO.[XIGY<_@RDTS>,*5#,?5?YZP_$11SD]0$*C6W*,\;A-
M2K@<G6-^0'_29DRN\Z+A^^KT$UFMG])TH:Q<^ DF:QM:DHV&BP9O6<#%2_CG
M'VU6I93"JD'*ZQF8"7#VEQ,0D9C/4SSZ\:6L+ZY>C=Q3,[GLO@83 48'&""%
MV!T4T< <676!0ZRB> H#8#V-!@?L-9B7ALQQ\G]C7.,ION@X>AO72?P'F#XU
MS=>'%M[^^8NGS\DW>/O/LQ/Z*DWL=/T6%^B$&Z/GZ9.GQ_M/7LIOCV$0<.?"
M_OJ7%A-XYL<_'!S@^ @NHD8152T.A4TG>'?K7]BP!SN7_2NQD6_R'3EM]UN=
M;*Y/CJ<BZKCAWI01F-245FZRID4;W"Q4Q]<$,9"??^!E]X.7-@7CTGJQ/"HI
M15HP=TUQO\()A).8P&VE^!\%".%>L'_M789E+@!+^,J.[K>)4()O?# 2$WR1
M58+DJ0A[D146V(/["%/:]D\)3^"^+UM69C*N:0DF$FUTR9&[RR@?1===QE<X
M:9,T+42A'.%3]PY'@@]H&O%)5CP<55!<7T9[V7ZZSRK_?8S66;9 -0:N=DHH
M ?H1O-HEO3=<WJ\_1[L-NJT-NOD.?>\"P'*\G_4?;L>>-)^UDQJ..!00LXG[
M-N7 0;D'/E;.V<U<; 5TX0Z?'-W<J!P,OM3R^G3G@Z.1CG4/Q!ME2_7AS.(+
MQ,ZLW,BX3>2%2=])J&N69G3NQFC0E+C+JA0>/+V4Z)AGB,!SXY;=\#B:P<,1
MO -7S=,4;BAXOXNTF"[Q1O GP_><O6' #[#OC/&C0MV[';:E'7:U_0V&A]TV
M-]E-Q!W/NB\1>3R[^L0>+.&I""1<CH?499HGT1[\@8_B\8Q"X5>V\EXV"N)2
M&,.ILD\(+\[X)._/$. I9M)=9INI:SI1V",Z]+[)2\11$W_F"T$6:#=:\[_7
M?A]ZH=Y1/_5&O4*GB+=5+N"LAPWY"30)/8YFJ"HQF4C2<YMS3E'W9Z-(\(CI
M%0HYSWR!J"KT%MD((3.C7\3'XN>5=;W>.5/F&BG$V(7@=[":-1&II_<?5G/R
MZ^DOIS^=_HKE4,=OWT2_GOYV>GY\?OKN[=FNP.1[*3 Y@>%G%N )!AUX$AFF
M/OC8.UL%MB>HPB989M+MJ7D2W$O\% ]ON0MG;R^</7FHX>P%R.<LFXJT4NR4
M0WM_LHCV\^\^I"T15S &!M*^H:H9RH$&B-VRR,GBLWHGK&L@XTU\VP4H'BR-
M+ZM%R8$><4WQ5_(;L%+J+,DP,]SS.XR@I&BI&0 3JT!4:%T81!T].WRVEW(Z
M>F\V<D-+TEVHY?9CH0.2]^\'DE!W@BI.GLG,-]8V]O/_LSBKC$'/=2Q[2<IQ
M0ZRBYI\3B@U6GB36RL" C4QN 7RQD%.6*VV&]@*=H^PK6)>52BVRJF[XP9,E
M^2A\!3I!8*(G;25HB@C.O;1(XBI:IO _>^Q=8M)ED:N*IK!&:-O;R>$!OW@[
M"2:S=JNY9RJC.-'!:2DL:@</L+[D.]O+QZ0GX-6&IMH5UTI@&ESU1;YT?AQF
M3^KH D._% $;N!%[3/:NE0GKUE:UD)P)PI3&SR/?L\%Q8WV1:81OP4("'\%P
MX!Y&-XYLEF=HW'1['KA!C37"  (+,EQ\,\8[A<@<A\:A.J!:1;Q5DDGVW#%L
M(8IN[]4[37@'0>>-SN0Z^D5.69"X\[3 FBG\'?^(E8F<UL=#W]-YS<$M>V;'
M@T9 6^18FMB)@]A(!DFL_!C3V4V4IS'HNH.#)_]AI.UGU,J_L5;FD(?$7Q+4
MV483AW?C^F!YL'L"P[V=BB6$4"=;- .5"^^"2K06[/*:Y^U@6SO8UK?A^_GS
MZ;W-4P&!VAL^X4@=8&VI :*N_6&?HM-^R:IXR/5E238/%]#B>2J\%&5;@_5#
ME>+6T^D88-;H\HTUST5!5:8L*@*8/'OR?&0T+IFD]%YD N9+2FLX" SQ7SC3
MP!AW,K3*^&Y\#S,@MB8-[.39DQ^/;7;-YL'9V+/UEUXI@#$8T2H!:Y3Q!=$>
M!X\1RU0O,E2^,_T]63WR5OH%G"$46FX@\$V535J=QF.<,,RH'OT.+G[[W LW
M@8N?WS4XNQ^EPD&JL$!B<IMV[P,7I\T9#$"1/S(JV2ID4IEI4<>K!<HR5<1<
M;^XNL<$H<.?B+.G ^T1KPUQEH-\1N$>T':(]297U#RP,!^!=9ED-7CO9FF,L
M\LG;Q)$J*!L[8=3/#&-B.*J^-"GJQ_XGXP"1<P;_DVXRUG&G/!*M^'__4;QQ
M=+;+!L8MLRCY2B_[N&(X,!(.:L"TEIF9[!0A+'S.XEU^*C$*+-$-NIDW5_]^
M,'[6.QJ<1JXVFF+:%*Z8MFB@H:M]J=<=9@V/AV9I2(,FE.T5]X+-_,0&ANQU
M-!3_0IQ>.(WC8IK%2"I$40#DX&*6F2WE0!Y\6O39_4^+OGM/*5!*B9Z=OWO]
M?Z+C]^\_G+P^I=1H].'TE[^=?P<)TI<K'8B3V'>D$3] ZH!(YG1DCRG3&#-%
MA5@J8"H*BK;Q?J3O::)325K#",D*Q;A7E=&F0:4T&%* C39HO?>&:(\4?=YE
M>0VJJ1JSC4#%RT%LH"[5H"BX5WAA!3/R>'@4C+E606&'(VD7< MM?)"6:I8+
M^B-X1)V"/P##P$KRZ11\]8;1:#*5=DUH'HN2P*VKP!VDLJXP0(PYF7.;[PW6
M$!6</+GK%!5X$(A7E*$DH3H:GN%4K;D-$5J)<I\(Y4N!##[1GB&*@L/0A9AQ
M7#8064<27)U@8< ,_HU8*CE\.'GH;JZCIB-SMF <NS$(9AIFA];(/>W5SK*[
M=>0"4F)V0 JV/@+,[0C-. Z@#\4R,:ZM](;>,9O$ !NX[48A0(O9$F H'/YP
MPP7,4YGX_D*/?.[<AMLO6CY1@+PS!N2]QY#TUPO<.KB?UHA:)$6G2O &CB6,
M,'YA!)QKX:.PVIJU&[P$&-P78W7TR3B"3+P!4 Z^#:A)4W[PM8/%HUC_5?='
MD+#PJF[G"[-!:<=-N/8%/YI1TH_S@Z5]-XZ#Q1ID2?'?(#IUKF)2>$)AH0O,
M25&D! NOB87,!WJ:P\C%E6H.B\'US(VBG$9,=L9>DG.W\V\__F1W_GO$Z2:&
MR?-]O#2U.>H7*.4H4V(&&2"+9&J%F9-^:S=3MVAG#LMA23=!.(TB,)<:8A\L
MN#A.P(K#\&5,3G*78LDBC''D=?=LZ=A:7LK8,D+[H0,V!MG;!CN54[QM \>8
ML'WRCC7&(%EVDGWF*DCFX WMIWD*MV @]$*F=\\;3B4$C_Q SF7AXS"@/ 57
M%\'R<I.182_M&8J$> V#1)TZCDH5&P$-@939L*<7M#AM'E=R=S5"GHINGM(I
M2]&2'!=J/$2)+@GEDE_.D?\:7S/48M [(M)9I'.!^9F75;K19/H/KT'=(C'L
MY9 HW*(1^R="RDV6');#VJ'+%!'TD[CX%"45&)6\FD6Z%(4!"Q<+0E8)Y]%#
M7)=>0O?;!([Y9[ODMW"ER,(R&]QDMD Q@F*9P_:\2O-R8=FI/J07%#F$?71.
M1=_@![3Y1=RX_?NQR)BA%CZLHY]3N"S.;=4J*U544V.?C%07T(HP]%96N)T\
ME@I<8EE.,ZG]3!ELO2"5Q[6C1A0[A31EYX*LJM*KDK545H V;DUY<8G2V@?:
M\(77>49UG!/['5>_/$"A?K'_Y"Z431:JFR3-LZN4B8Z\_+#(!"($IPTF)>PO
MT2R&<ZGF5/EH7>X,,[AQ7J5Q I=>J[-*FS4S.%8X=(3X"!-.S[,4X633/,[F
MR Y13-OYI$)!I]0#<:?C*8\A?SS^Z[$A6ECK-CB#B>V/M ZY&WU)'3MSAZZ@
MRCH_/JAN&>S #*-V$SC ,4=?Q13:,E5MW#* BKWC7._A8*=0.)$*US)5/&X7
M):MWD*$=9.B;0H:&M:).(.I=;0@(+)^(LVDI-NO,SS'52_HB?5VV.8>'K[(R
MYYX#'4L8E9%U3XP+8.(3%9R?SK\/M^68*AP)FXJ9L!G<%4=F*$L0/5TD955S
M-A%])U2-LOLXE#%M&?*"(?XYV\T2ZZ:33-V7P_A[ST<>LRDE0(CD@4I7^Q2C
M((_1DT.\@H0!/8*Z^*J$^8\3F#5T'CFZ3W. F!P.DF-F5C@W3*S$3/0#/%V_
M Z19-@NPHBMS/"A1QJXLTJ9C4L85''L7+.7:&+7@;I\J:14O2A_/*FTG/YTD
ML@A^[07L*@2AY3TWN\WC5F^<MN;$_H!9J8.@.C9/*'H.T--VW,H9K->+COJO
MUH98(K';E%O9E/Z>+&BY>?;-G%,T-A&N.P_N!9HT733:R68'#$6'U@[T/FT<
M\N[\@VD7C;U]^-;Z:*S'C?!&(SMGG+98'95=XD]N(2;KI;,YB.@E'#Q,JHH#
MQ=ZP2)^'^,2XDR2Z(."NI%[P_\_1?/!YW%%/UQX)A0.^;:[[Z?%?2B _A#UP
M3B92Z@BV;9*B,C</-O$7TM:T@EB'Y>HYPJR:^=U^=$9@XL&I5]%;N\B^PI<L
MV;SS!AA6,?$5+H^:3Q2?6(=M#7],X.5>'6:MZ.&@,%/WA1%^7])V.NO66QE1
MGG &IP][TJQ^5E4/-')!99"-&:PM)B&6"C*8%3:-R6A"0AOJS S>,9LCFE#H
M5ERCR=PO@Z 0AS]*/X<A"5\0O:QQT@>:]+207$R=%B;Q8>,6FD#/3U[XJ0KK
MTZT>3F?*2,5AQG09VI*I[8F:?L8C.VORI?L)6H@96.2%!,#<>Q94+*YRVWHI
M9F456!)D)5@DTZRM\'8#6+%!@-K8@XO)<Q/<K@DWSEOE5H1>'VM%->J'F<3Y
MGMD./@32;+:_U$F&>TJ?TT[H,?\O0CP1AZ^LG,-V36=JDM93 X_3AQ8'(OJ
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MA#JZ>@I>GNUEHYL=(5;WUQ8"P>U[Y%RCAPZ?+&1=VL2#*E7WC4,?],R:G'O
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MWT&!0$@2QY=(TP[S;1YBFT&0<<#R/H573*D<L^>$5PJ>WE2?W'"*I&-+"J/
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M)2;^] D?%3Y4=/6,/#SK^L7^D[LH]OAR^_J](']4=F-G<G];DWNQV92/O\J
M\DRGE;MPF%7M6YI2GC<AN(.E6UL&?KG7ZTOP/&Q-<C?AU<UK+][+D:!"BJ
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M7(%^=M<-+;Y8H%^;3*EX( G.YK">1VP8@^T#"1L[<X00Z+4"#8?NP7BM#>_
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M^)EFW9$ A<9DH<GZ>D214"*!G9(I@Q?FH--RO(HV1'V9+:SI,K2-]O"Z+SZ
MSB2TQ3?S3Y\11F?2-*'YV<&+=O"B6X<7N69VE ^@C0M&!6:.8PK^@CK (C6C
M=K3:%EVO% /%P9@&CI4VG!QM!3N*?356/X%JZ]XE<&FJ%'Q*H\.+=C[ADT7(
M!-2 QBK]1D'K6:^>%R835NN3MK%Z!D.VRA'!VCK$,X*6&85OUJ.BU[V'$!!0
M3-MQA>B[<(#&UQ?=,]S"'1WS0??1^/YC9NXU,[=N*4+^5R*;0IXH>;B2"IF
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MG@WNUW^6U2?YV$1V7,#Y9^[3!ZN%R@0GT505X_..[8O<*]4PFVU'-: *1DZ
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M47461U;,D5@!S5<X8XUB14V9XQF(KVY,F2-Q(XHTQW(WF"':@B788G7-$T!
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4!08     !0 % $T!  !$IP     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>mxct-20240611x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mxct-20240611.xsd" xlink:type="simple"/>
    <context id="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001287098</identifier>
        </entity>
        <period>
            <startDate>2024-06-11</startDate>
            <endDate>2024-06-11</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Tc_iait9iqWe0KzzpCYJsxaDQ_2_1">0001287098</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Tc_W0s3bSF1-ECZEbKOKnVvcg_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_fvUiFGb4Y0Ce_xWlj6btjg">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_DsobfeVuO0uPz7M-hQxZ6Q">2024-06-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_FVIIqARxg0Ss8Fh84eeMHQ">MaxCyte, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Tc_kVnQpRtAc0ePgKgxHRurXQ_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Tc_OCtxRVeRQkGdbxkqX2c8bg_1_2">001-40674</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Tc_SOLMHBfThkuE2YUNqBnhmA_1_4">52-2210438</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_7jEmmpSrqEa6vaqnpyjk3w">9713 Key West Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_jSwY3g319EiFeFO2PWuIRA">Suite 400 </dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_O7KtVj3NQkWqMD9sA8Et2A">Rockville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_p-THdNZc1UqmSNVfu4JHtQ">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_tbrWHT1eVkOeWLcow9WUvw">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_3SngV7YVcEiAETBCSYJJwA">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_T8XdR7A6TUaSJj9GBQQ-_w">944-1700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_KXy9C2EscU-QCsiduycjPA">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_N6m9dfRbdU-F_yNblfKkkg">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_MXyRRIkXa0WWuwHNghmf9A">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_XKCLBZZAMU6VwWXpBp9PrA">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Tc_k5kDnfOCtUKedGE9g5yx7w_2_0">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Tc_8TuH02i7NUeaYaDbGrKgdw_2_2">MXCT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Tc_OcyzT0M0d0-ZFCEVTJV8wg_2_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_Yo0oUdZ6K0yjLYQR3yBPSA">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="Duration_6_11_2024_To_6_11_2024_ndVILfMhhkCpjymdNgTUsg"
      id="Narr_D_l7W8nag0KncLV-er1OKA">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
